Cholesterol oxidase from Brevibacterium sterolicum

Abstract

The invention concerns a cholesterol oxidase, a process for the production of a recombinant cholesterol oxidase, a DNA sequence suitable for this process which causes a cytoplasmatic expression of the recombinant cholesterol oxidase in a host bacterium as well as the recombinant cholesterol oxidase obtianed in this way.

Description

The invention concerns a cholesterol oxidase from Brevibacterium sterolicum, a process for the production of a recombinant cholesterol oxidase from Brevibacterium sterolicum, a suitable DNA sequence for this process which results in a cytoplasmic expression of the recombinant cholesterol oxidase in the host bacterium as well as the recombinant cholesterol oxidase obtained in this manner.

Cholesterol oxidase is of major importance for the enzymatic determination of cholesterol. It catalyzes the oxidation of cholesterol to cholesten-3-one and H.sub.2 O.sub.2. Cholesterol oxidase from various organisms such as Pseudomonas, Mycobacterium, Nocardia, Arthrobacter and Brevibacterium have already been described (T. Uwajima et al., Agr. Biol. Chem. 37 (1973), 2345-2350). All these known cholesterol oxidases are secreted proteins. The soil bacterium Brevibacterium sterolicum KY 3643 (ATCC 21387) has a particularly high activity of cholesterol oxidase. Three isoenzymes of cholesterol oxidase are known from this bacterium which differ in their isoelectric point, substrate specificity towards various steroids, affinity for cholesterol at the pH optimum and in their DNA and amino acid sequence (EP-A 0 452 112 and EP-A 560 983). Cholesterol oxidase I from Brevibacterium sterolicum has a low affinity for cholesterol (K.sub.M 1.1.times.10.sup.-3 mol/l) and can only be obtained in a low yield from Brevibacterium sterolicum. It has already been attempted to express a complete DNA coding for cholesterol oxidase I in E. coli, but this has not yet succeeded (K. Fujishiro et al., Biochem. Biophys. Res. Com. 172 (1990), 721-727, T. Ohta et al., Gene 103 (1991), 93-96). The expression of special deletion mutants of the DNA coding for cholesterol oxidase I which were fused with parts of the lac z gene also did not lead to a satisfactory expression in E. coli (T. Ohta et al., Biosci. Biotech. Biochem. 56 (1992), 1786-1791). The cloning and expression of further cholesterol oxidases from Brevibacterium sterolicum is described in EP-A 0 452 112. However, expression of these DNAs likewise does not lead to an adequate amount of active cholesterol oxidase.

The object of the invention was to provide a cholesterol oxidase with a high affinity for cholesterol in large amounts and in an active form.

This object is achieved by a cholesterol oxidase which has the amino acid sequence shown in SEQ ID NO 2. This cholesterol oxidase is obtainable from Brevibacterium sterolicum or can also be produced by recombinant means.

It has surprisingly turned out that such a cholesterol oxidase can be produced recombinantly in a large amount and in an active form. This cholesterol oxidase has a molecular weight of 60 kD, an isoelectric point of ca. 5.5 (each measured in the Phast System, Pharmacia LKB) and a K.sub.M value for cholesterol of 1.times.10.sup.-4 mol/l (in 0.5 mol/l potassium phosphate buffer pH 7.5 at 25.degree. C.) and is active in a pH range of 5.5 to 8.0.

It has turned out that this cholesterol oxidase can be obtained in a large amount and in an active form when a DNA is used for a heterologous expression which codes for a peptide with cholesterol oxidase activity and is selected from the group

a) the DNA sequence shown in SEQ ID NO 1 or the DNA sequence which is complementary thereto, b) DNA sequences which hybridize with the DNA sequence shown in SEQ ID NO 1 or with fragments of this DNA sequence, c) DNA sequences which, without degeneracy of the genetic code, would hybridize with the sequences defined in a) or b) and which code for a polypeptide with the same amino acid sequence, wherein this DNA has one of the sequences shown in SEQ ID NO 3, 4 and/or 5. A DNA is preferably used which has the sequence shown in SEQ ID NO 1. However, it is also possible to replace degenerated codons by other codons that code for the same amino acid in a manner familiar to a person skilled in the art. Furthermore codons coding for additional amino acids can be added at the 5' end, at the 3' end or also within the sequence shown in SEQ ID NO 1 provided the DNA variants obtained in this way hybridize with the DNA sequence shown in SEQ ID NO 1 under the usual conditions (see T. Maniatis et al., Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 1989). In addition the DNA used should have one of the sequences shown in SEQ ID NO 3, 4 and/or 5 and code for a peptide with cholesterol oxidase activity. A peptide with cholesterol oxidase activity is understood as a peptide which catalyzes the oxidation of cholesterol (5-cholesten-3-.beta.-ol) to 4-cholesten-3-one and H.sub.2 O.sub.2.

The invention therefore also concerns a DNA which codes for a peptide with cholesterol oxidase activity and is selected from the group

a) the DNA sequence shown in SEQ ID NO 1 or the DNA sequence which is complementary thereto, b) DNA sequences which hybridize with the DNA sequence shown in SEQ ID NO 1 or with fragments of this DNA sequence, c) DNA sequences which, without degeneracy of the genetic code, would hybridize with the sequences defined in a) or b) and which code for a polypeptide with the same amino acid sequence, wherein this DNA has one of the sequences shown in SEQ ID NO 3, 4 and/or 5.

With such a DNA it is possible to obtain an at least 10-fold higher activity of the recombinantly produced cholesterol oxidase in a crude extract than with the previously described processes and cholesterol oxidases.

The invention in addition concerns a process for the production of a recombinant cholesterol oxidase by transformation of a suitable host cell with a DNA according to the invention which is present in a suitable expression system, culturing the transformed host cells and isolating the cholesterol oxidase formed from the cytoplasm of the transformed cells.

With this process it is surprisingly possible to obtain a recombinant cholesterol oxidase in a large amount and in an active form from the cytoplasm of the transformed host cell. In this process the DNA used can contain an additional nucleotide sequence at the 5' end which has a translation start codon but no stop codon wherein this additional nucleotide sequence does not lead to a shift in the reading frame and does not represent a functionally active signal sequence for the secretion of the recombinant enzyme formed. The length of this nucleotide sequence is about 3 to 90 base pairs.

The additional nucleotide sequence preferably has one of the sequences shown in the sequence protocols 6, 8, 10, 12, 14 and 16 instead of the native signal sequence.

A preferred subject matter of the invention is therefore a process for the production of a recombinant cholesterol oxidase in which a DNA according to the invention is used which has one of the sequences shown in SEQ ID NO 6, 8, 10, 12, 14 or 16 at the 5' end.

The host cells used for the recombinant production are transformed according to known methods (see e.g. Sambrook, Fritsch and Maniatis, Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor 1989). The transformed host cells are then cultured under conditions which allow expression of the cholesterol oxidase gene. Depending on the expression vector used, it may be expedient in a well-known manner to add an inductor (e.g. lactose or isopropyl-.beta.-D-thiogalacto-pyranoside (IPTG)) to the culture medium to increase the temperature or to limit the supply of glucose. Isolation of the recombinant cholesterol oxidase from the cytoplasm of the transformed cells is then achieved according to known methods.

With this process it is possible to obtained the cholesterol oxidase according to the invention as a recombinant enzyme in a yield of 8-20 U/ml. In contrast expression of the complete cholesterol oxidase gene which contains the signal sequence only results in a yield of less than 0.1 U/ml.

A preferred subject matter of the invention is a DNA according to the invention coding for a peptide with cholesterol oxidase activity which has one of the sequences shown in SEQ ID NO 6, 8, 10, 12, 14 and 16 at the 5' end. The sequences shown in the sequence protocols 18, 20, 22, 24, 26 and 28 are particularly preferred. These DNA sequences according to the invention are preferably present cloned in an expression vector. This DNA can be used to obtain the cholesterol oxidase according to the invention in any amount in bacteria that are conventionally used for the recombinant production of proteins. The expression is preferably carried out in E. coli.

The invention therefore also concerns a recombinant cholesterol oxidase which is coded by a DNA according to the invention and has one of the amino acid sequences shown in SEQ ID NO 7, 9, 11, 13, 15 or 17 at the N-terminal end.

This recombinant cholesterol oxidase is equally as suitable as the other cholesterol oxidases known from the state of the art for an enzymatic test for the determination of cholesterol. If necessary recognition sequences for specific proteases such as e.g. IgA protease, enterokinase or factor Xa can be integrated between these N-terminal sequences and the amino acid sequence of the mature cholesterol oxidase by in vitro mutagenesis in a manner familiar to a person skilled in the art so that even after cytoplasmic expression of a cholesterol oxidase extended by these N-terminal sequences it is possible to cleave off such fused N-terminal sequences.

A preferred subject matter of the invention is a recombinant cholesterol oxidase which has the amino acid sequence shown in SEQ ID NO 21, 23, 25, 27 or 29 as well as the use of such a recombinant cholesterol oxidase in an enzymatic test for the detection of cholesterol. In this process the H.sub.2 O.sub.2 formed in the cholesterol oxidase reaction is preferably determined in a subsequent indicator reaction as a measure of the cholesterol present in the sample.

The plasmids pUC-chol-B2-BB (DSM 8274), pmgl-SphI (DSM 8272) and pfl-20AT1-SD (DSM 8273) mentioned in the examples were deposited on May 05, 1993 at the "Deutsche Sammlung fur Zellkulturen und Mikroorganismen GmbH", Mascheroder Weg 1b, D-3300 Braunschweig.

The application is elucidated in more detail by the following examples in conjunction with the sequence protocols and figures.

SEQ ID NO 1 shows the nucleic acid sequence of the cholesterol oxidase according to the invention. SEQ ID NO 2 shows the amino acid sequence of the cholesterol oxidase according to the invention. SEQ ID NOS 3-5 show nucleotide sequences from DNAs according to the invention coding for a peptide with cholesterol oxidase activity. SEQ ID NOS 6-17 show the N-terminal sequences of recombinant cholesterol oxidase genes according to the invention (SEQ ID NOS 6, 8, 10, 12, 14 and 16) and the N-terminal amino acid sequences thereof (SEQ ID NOS 7, 9, 11, 13, 15 and 17). SEQ ID NOS 18-29 show the nucleic acid sequences and amino acid sequences thereof of cholesterol oxidases according to the invention.

They denote the following:

______________________________________Signal sequence Complete sequence Construct______________________________________SEQ ID NO 6-7 SEQ ID NO 18-19 plac-Chol-cytSEQ ID NO 8-9 SEQ ID NO 20-21 ppfl-Chol-cytSEQ ID NO 10-11 SEQ ID NO 22-23 ppfl-MSN3H-Chol-cytSEQ ID NO 12-13 SEQ ID NO 24-25 ppfl-MSN4H-Chol-cytSEQ ID NO 14-15 SEQ ID NO 26-27 ppfl-MSN4R2K-Chol-cytSEQ ID NO 16-17 SEQ ID NO 28-29 ppfl-MVM3H-Chol-cyt______________________________________ SEQ ID NOS 30-33 show four oligonucleotides for amplification of a fragment of the cholesterol oxidase gene according to the invention. SEQ ID NO 34 shows the sequence of an adapter oligonucleotide for the in vitro mutagenesis of the cholesterol oxidase gene according to example 5.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows the plasmid pUC-Chol-B2-BB.

FIG. 2 shows the plasmid plac-Chol-cyt.

FIG. 3 shows the plasmid ppfl-Chol-cyt.

FIG. 4 shows the plasmid ppfl-MSN3H-Chol-cyt.

EXAMPLE 1

Cloning of the gene for cholesterol oxidase from Brevibacterium sterolicum

Brevibacterium sterolicum (BMTU 2407) is cultured in 500 ml nutrient broth (Difco) for 20 h at 30.degree. C. The cells are harvested by centrifugation. The cell mass obtained in this way is resuspended in 20 mmol/l Tris/HCl pH 8.0 to 0.4 g cell wet weight/ml. 5 ml 24% (w/v) polyethylene glycol 6000, 2.5 ml 20 mmol/l Tris/HCl pH 8.0 and 10 mg lysozyme are added to 2.5 ml of this suspension and it is incubated for 14 h at 4.degree. C. Then the cells are lysed by addition of 1 ml 20% (w/v) SDS and 2 mg protease K and incubation for 1 h at 37.degree. C. An equal volume of 20 mmol/l Tris/HCl pH 8.0 is added to this solution and then 1 g CsCl and 0.8 g ethidium bromide are added per ml. This solution is separated by ultracentrifugation for 24 h at 40,000 rpm in a TV850 vertical rotor (DuPont). The DNA band is then withdrawn with an injection syringe. The removal of ethidium bromide and ethanol precipitation of the DNA is carried out as described in Sambrook et al., Molecular Cloning, A Laboratory Manual (1989).

7 .mu.g of the DNA obtained in this manner is partially cleaved with the restriction endonuclease NlaIII (New England Biolab), separated electrophoretically on a 0.8% agarose gel and a size region of ca. 2-12 kb is cut out. The DNA fragments are isolated from the gel, cleaved with SphI and subsequently ligated into a plasmid vector pUC19 treated with alkaline phosphatase from calf intestine. This ligation preparation is transformed in competent E. coli K12 XL1-blue (Stratagene, Catalogue No. 200268). The transformed cells are plated on agar plates with LB medium containing 100 .mu.g/ml ampicillin and incubated overnight at 37.degree. C. The fully grown colonies are transferred onto nitrocellulose filters (Schleicher and Schull), lysed by treatment with toluene/chloroform vapour and the colony side of the filter is transferred onto indicator plates (see below). Cholesterol oxidase activity is tested on these indicator plates by a 15- to 30-minute incubation at room temperature.

Clones which show a colour reaction are selected and isolated. As a control these E. coli clones are streaked onto an agar plate with LB medium containing 100 .mu.g/ml ampicillin, incubated overnight at 37.degree. C., for verification the colonies that have grown on are again transferred onto two different nitrocellulose filters and lysed as described above with toluene/chloroform vapour. A filter is again placed on one of the indicator plates described above and the other filter is placed on an indicator plate without cholesterol. A positive colour reaction was only seen on the complete indicator plates containing the substrate cholesterol. This therefore demonstrates that the colour reaction caused by the corresponding E. coli clone is in fact due to active cholesterol oxidase.

Preparation of the indicator plates:

For the plate test to determine cholesterol oxidase activity, 100 ml 2% low-melting-point agarose (Sea Plaque BIOzym 50113) is melted and a solution of:

48 mg 4-aminoantipyrine (Boehringer Mannheim GmbH, Catalogue No. 073474) 306 mg EST (N-ethyl-N-sulfoethyl-3-methylaniline potassium salt (Boehringer Mannheim GmbH, Catalogue No. 586854)) 2.5 mg horseradish peroxidase, degree of purity II (ca. 260 U/mg (Boehringer Mannheim GmbH, Catalogue No. 005096)) 60 .mu.l sodium azide solution (20%) 10 ml 1 mol/l potassium phosphate pH 7.2 150 mg cholic acid sodium salt (Merck, Catalogue No. 12448) 10 ml cholesterol substrate solution (see below) H.sub.2 O to a volume of 100 ml pre-warmed to a temperature of 42.degree. C. is added to the melted agarose, carefully mixed, 10 ml portions are poured into Petri dishes and kept in the dark for storage. Cholesterol substrate solution:

500 mg cholesterol (Boehringer Mannheim GmbH, Catalogue No. 121312) is dissolved in 12.5 ml 1-propanol (Merck, Catalogue No. 997), mixed well after addition of 10 g Thesit (Boehringer Mannheim GmbH, Catalogue No. 006190) and water is added to a volume of 100 ml. The substrate solution can be stored for several months at room temperature.

EXAMPLE 2

Characterization of the cholesterol oxidase gene

The plasmid of a clone obtained according to example 1 (pUC-chol-B2) is isolated according to standard methods and subjected to restriction mapping using the restriction endonucleases BamHI, EcoRI, KpnI, XhoI, PstI. It turns out that a DNA fragment from the genome of Brevibacterium with a size of ca. 5.5 kb is inserted into the plasmid pUC-Chol-B2. By subcloning various partial fragments of this 5.5 kb piece and subsequently determining the cholesterol oxidase activity of the E. coli clones obtained, it is possible to narrow down the cholesterol oxidase gene to a BamHI fragment of 2.3 kb size. The plasmid with this fragment is denoted pUC-Chol-B2-BB (FIG. 1). The DNA sequence of this fragment is determined and examined for a reading frame which codes for cholesterol oxidase. The sequence of this reading frame for mature cholesterol oxidase is given in SEQ ID NO 1.

EXAMPLE 3

Construction of a plasmid for expressing the cholesterol oxidase gene with a heterologous signal sequence

Comparison of the N-terminal amino acid sequence of cholesterol oxidase which was isolated from Brevibacterium with the entire reading frame coding for cholesterol oxidase from pUC-Chol-B2-BB shows that the first 52 coded amino acids of the gene sequence are absent in the mature protein. These 52 amino acids have the structure of a typical export signal sequence of gram-positive prokaryotes (von Heijne, Biochim. Biophys.

Acta 947 (1988), 307-333). In order to construct recombinant cholesterol oxidase genes in which this signal sequence is replaced by other sequences, a 387 bp DNA fragment from the plasmid pUC-Chol-B2-BB is firstly amplified by means of PCR using the oligonucleotides shown in SEQ ID NOS 30 and 31. This fragment contains the region coding for the N-terminal part of the mature oxidase with a new SphI cleavage site directly in front of the N-terminus of the amino acid sequence of the mature enzyme. This PCR fragment is cleaved with SphI and PstI and ligated together with a PstI EcoRI fragment from pUC-Chol-B2-BB which contains the remaining part of the cholesterol oxidase gene into the expression vector pmglsphl cleaved with SphI and EcoRI and in this way the vector pmgl-Chol-SB is obtained. In this vector the cholesterol oxidase gene contains a signal sequence from Salmonella typhimurium that is functional in E. coli (described in WO 88/093773).

EXAMPLE 4

Construction of a plasmid for expression of the cholesterol oxidase gene without a signal peptide-coding sequence under the control of the lacUV5 promoter

A DNA fragment of ca. 1.85 kb in size which contains the entire part of the coding sequence of mature cholesterol oxidase but not the sequence coding for the signal peptide is cut out of the plasmid pmgl-Chol-SB by treatment with the restriction endonucleases SphI and BamHI. This fragment is inserted into the plasmid vector pUC19 which has previously been cleaved with SphI and BamHI. In the plasmid plac-Chol-cyt obtained in this manner the cholesterol oxidase gene is present in the correct reading frame and is fused to the first ten codons of the lacZ' gene from pUC19 and is under the control of the lacUV5 promoter (FIG. 2).

EXAMPLE 5

Construction of a plasmid for the expression of the cholesterol oxidase gene without a signal peptide-coding sequence under the control of the oxygen-regulated pfl promoter

A DNA fragment of 432 bp in size which contains a Clal cleavage site in front of the ATG start codon is produced from the plasmid plac-Chol-cyt by the PCR technique using the oligonucleotides shown in SEQ ID NOS 32 and 33. This PCR fragment is cut with ClaI and PstI. In addition a fragment with the remaining C-terminal part of the cholesterol oxidase gene is cleaved from the plasmid plac-Chol-cyt by treatment with the restriction endonucleases PstI and BamHI. Both fragments are simultaneously ligated into the expression vector pfl 20AT1-SD cleaved with BamHI and ClaI. The correct ligation product now contains the reading frame of mature cholesterol oxidase fused to the first ten codons of the lacZ' gene from pUC19 under the control of the oxygen-regulated pfl promoter (FIG. 3). This plasmid is denoted ppfl-Chol-cyt.

EXAMPLE 6

Construction of a plasmid for expressing the cholesterol oxidase gene with an alternative N-terminal fusion sequence

In order to remove the SphI cleavage site of the plasmid ppfl-Chol-cyt located in the 3' untranslated region of the cholesterol oxidase gene, the plasmid DNA is cleaved with SmaI and EcoRV and again religated. 100 ng of the plasmid ppfl-Chol-cyt-.DELTA.term formed in this manner is then cleaved with the restriction enzymes ClaI and SphI. The DNA fragment of 4.76 kb in size which is formed is electrophoretically separated in low-melting point agarose, cleaved and eluted (Glassmilk.RTM.-Kit, Bio 101). 100 ng of the DNA fragment purified in this manner is admixed with 50 pmol of an adapter oligonucleotide with the sequence shown in SEQ ID NO 34 (in which "N" denotes an equimolar mixture of all 4 bases) and treated for 2 hours at 37.degree. C. with T4 DNA ligase. Subsequently the mixture is admixed with a mixture of 4 dNTP's (final concentration 0.125 mmol/l) and treated for 40 minutes at 37.degree. C. with Klenow DNA polymerase. The plasmid DNA obtained in this manner is transformed in E. coli XL1-blue (Stratagene). Individual colonies of the clones obtained are compared with the aid of the colony activity test described in example 1 with regard to their cholesterol oxidase activity. Clones with a high cholesterol oxidase activity are isolated and the plasmid DNA is characterized by restriction analysis and DNA sequencing. The plasmid of a clone with a particularly high cholesterol oxidase activity was found to have the sequence SEQ ID NO 23. The plasmid concerned is denoted ppfl-MSM3H-Chol-cyt-.DELTA.term. It is to be expected that further clones suitable for a particularly high expression may be found in the described manner after isolation and characterization of an adequate number of different clones. In order to complete again the 3' untranslated part, the plasmid ppfl-MSM3H-Chol-cyt-.DELTA.term is cleaved with ClaI and XhoI. A DNA fragment of ca. 1.1 kb with the translation initiation region and the N-terminal part of the cholesterol oxidase gene is isolated and ligated into the plasmid ppfl-Chol-cyt which is also cleaved with ClaI and XhoI (FIG. 4). The plasmid obtained is denoted ppfl-MSN3H-Chol-cyt.

EXAMPLE 7

Comparison of the formation of cholesterol oxidase by the various expression plasmids in E. coli

The plasmids pUC-Chol-B2, pUC-Chol-B2-BB, pmgl-Chol-SB, plac-Chol-cyt, pplf-Chol-cyt, ppfl-MSN3H-Chol-cyt are each transformed in E. coli K12 XL1-blue. In order to compare the amount of enzyme formed, the clones are each cultured for 15 hours at 30.degree. C. in LB medium containing 200 .mu.g/ml ampicillin and the following further additives:

clones containing the plasmids pUC-Chol-B2, pUC-Chol-B2-BB, plac-Chol-cyt in which the cholesterol oxidase gene is in each case under the control of the lacUV5 promoter are additionally receive 1 mmol/l IPTG, the clone containing the plasmid pmgl-Chol-SB with the glucose-repressed mgl promoter receives no further additives, clones containing the plasmids ppfl-Chol-cyt, ppfl-MSN3H-Chol-cyt with the oxygen-regulated pfl promoter recieve 0.4% glucose and are grown in closed serum flasks that have been gassed with nitrogen in which the medium was adjusted with KOH to pH 7.0. After the culture is completed the cell density achieved is determined by photometric measurement of the turbidity at 420 nm. The cells of 1 ml culture broth are then sedimented by centrifugation in a microcentrifuge at 10,000 g and again resuspended in 0.5 ml redistilled H.sub.2 O. The cell rupture is carried out by 2.times.30 seconds ultrasonic treatment (Branson Sonifier, model 450, standard microtip, conical). The cell extracts obtained in this manner are used in the following enzyme test after appropriate dilution: for this the following are pipetted into quartz cuvettes:

3 ml potassium phosphate buffer (0.5 mol/l, pH 7.5) containing 0.4% Thesit.RTM. (Boehringer Mannheim GmbH, Catalogue No. 006190), 0.1 ml cholesterol solution (0.4% cholesterol, 10% l-propanol, 10% Thesit.RTM.), 0.02 ml H.sub.2 O.sub.2 (0.49 mol/l in redistilled water), it is mixed, after addition of 0.02 ml catalase (from bovine liver, 20 mg protein/ml, specific activity ca. 65,000 U/mg, Boehringer Mannheim GmbH, Catalogue No. 0156744 diluted immediately to 0.075-0.15 U/ml before measurement with ice-cold potassium phosphate buffer, containing 0.4% Thesit) it is again mixed, the solution is brought to a temperature of 25.degree. C. and subsequently the reaction is started by addition of 0.05 ml sample solution. After careful mixing the change in absorbance at 240 nm is monitored and the activity of cholesterol oxidase is determined from the linear region of the absorbance curve: ##EQU1## in which .di-elect cons. 240=15.5 mmol.sup.-1 .times.1.times.cm.sup.-1.

The values obtained for cell density and enzyme activity are shown in Table 1.

TABLE 1______________________________________ Cell density Units per cellClone/plasmid (A 420) density Units per ml______________________________________pUC-chol-B2 7.0 0.007 0.049pUC-chol-B2-BB 8.4 0.068 0.571pmgl-chol-SB 1.3 0.014 0.018plac-chol-cyt 8.6 0.725 6.235ppfl-chol-cyt 1.25 1.675 2.094ppfl-MSN3H-chol-cyt 3.7 1.463 5.413______________________________________

The results obtained show that using such constructs which cause a cytoplasmic expression of cholesterol oxidase, a considerably higher activity of the recombinantly produced cholesterol oxidase can be obtained than with those constructs which lead to a secretion of the recombinantly produced cholesterol oxidase.

__________________________________________________________________________# SEQUENCE LISTING- (1) GENERAL INFORMATION:- (iii) NUMBER OF SEQUENCES: 34- (2) INFORMATION FOR SEQ ID NO:1:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1683 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1683- (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:- TCG ACC GGG CCG GTC GCG CCG CTT CCG ACG CC - #G CCG AAC TTC CCG AAC 48Ser Thr Gly Pro Val Ala Pro Leu Pro Thr Pr - #o Pro Asn Phe Pro Asn# 15- GAC ATC GCG CTG TTC CAG CAG GCG TAC CAG AA - #C TGG TCC AAG GAG ATC 96Asp Ile Ala Leu Phe Gln Gln Ala Tyr Gln As - #n Trp Ser Lys Glu Ile# 30- ATG CTG GAC GCC ACT TGG GTC TGC TCG CCC AA - #G ACG CCG CAG GAT GTC 144Met Leu Asp Ala Thr Trp Val Cys Ser Pro Ly - #s Thr Pro Gln Asp Val# 45- GTT CGC CTT GCC AAC TGG GCG CAC GAG CAC GA - #C TAC AAG ATC CGC CCG 192Val Arg Leu Ala Asn Trp Ala His Glu His As - #p Tyr Lys Ile Arg Pro# 60- CGC GGC GCG ATG CAC GGC TGG ACC CCG CTC AC - #C GTG GAG AAG GGG GCC 240Arg Gly Ala Met His Gly Trp Thr Pro Leu Th - #r Val Glu Lys Gly Ala# 80- AAC GTC GAG AAG GTG ATC CTC GCC GAC ACG AT - #G ACG CAT CTG AAC GGC 288Asn Val Glu Lys Val Ile Leu Ala Asp Thr Me - #t Thr His Leu Asn Gly# 95- ATC ACG GTG AAC ACG GGC GGC CCC GTG GCT AC - #C GTC ACC GCC GGT GCC 336Ile Thr Val Asn Thr Gly Gly Pro Val Ala Th - #r Val Thr Ala Gly Ala# 110- GGC GCC AGC ATC GAG GCG ATC GTC ACC GAA CT - #G CAG AAG CAC GAC CTC 384Gly Ala Ser Ile Glu Ala Ile Val Thr Glu Le - #u Gln Lys His Asp Leu# 125- GGC TGG GCC AAC CTG CCC GCT CCG GGT GTG CT - #G TCG ATC GGT GGC GCC 432Gly Trp Ala Asn Leu Pro Ala Pro Gly Val Le - #u Ser Ile Gly Gly Ala# 140- CTT GCG GTC AAC GCG CAC GGT GCG GCG CTG CC - #G GCC GTC GGC CAG ACC 480Leu Ala Val Asn Ala His Gly Ala Ala Leu Pr - #o Ala Val Gly Gln Thr145 1 - #50 1 - #55 1 -#60- ACG CTG CCC GGT CAC ACC TAC GGT TCG CTG AG - #C AAC CTG GTC ACC GAG 528Thr Leu Pro Gly His Thr Tyr Gly Ser Leu Se - #r Asn Leu Val Thr Glu# 175- CTG ACC GCG GTC GTC TGG AAC GGC ACC ACC TA - #C GCA CTC GAG ACG TAC 576Leu Thr Ala Val Val Trp Asn Gly Thr Thr Ty - #r Ala Leu Glu Thr Tyr# 190- CAG CGC AAC GAT CCT CGG ATC ACC CCA CTG CT - #C ACC AAC CTC GGG CGC 624Gln Arg Asn Asp Pro Arg Ile Thr Pro Leu Le - #u Thr Asn Leu Gly Arg# 205- TGC TTC CTG ACC TCG GTG ACG ATG CAG GCC GG - #C CCC AAC TTC CGT CAG 672Cys Phe Leu Thr Ser Val Thr Met Gln Ala Gl - #y Pro Asn Phe Arg Gln# 220- CGG TGC CAG AGC TAC ACC GAC ATC CCG TGG CG - #G GAA CTG TTC GCG CCG 720Arg Cys Gln Ser Tyr Thr Asp Ile Pro Trp Ar - #g Glu Leu Phe Ala Pro225 2 - #30 2 - #35 2 -#40- AAG GGC GCC GAC GGC CGC ACG TTC GAG AAG TT - #C GTC GCG GAA TCG GGC 768Lys Gly Ala Asp Gly Arg Thr Phe Glu Lys Ph - #e Val Ala Glu Ser Gly# 255- GGC GCC GAG GCG ATC TGG TAC CCG TTC ACC GA - #G AAG CCG TGG ATG AAG 816Gly Ala Glu Ala Ile Trp Tyr Pro Phe Thr Gl - #u Lys Pro Trp Met Lys# 270- GTG TGG ACG GTC TCG CCG ACC AAG CCG GAC TC - #G TCG AAC GAG GTC GGA 864Val Trp Thr Val Ser Pro Thr Lys Pro Asp Se - #r Ser Asn Glu Val Gly# 285- AGC CTC GGC TCG GCG GGC TCC CTC GTC GGC AA - #G CCT CCG CAG GCG CGT 912Ser Leu Gly Ser Ala Gly Ser Leu Val Gly Ly - #s Pro Pro Gln Ala Arg# 300- GAG GTC TCC GGC CCG TAC AAC TAC ATC TTC TC - #C GAC AAC CTG CCG GAG 960Glu Val Ser Gly Pro Tyr Asn Tyr Ile Phe Se - #r Asp Asn Leu Pro Glu305 3 - #10 3 - #15 3 -#20- CCC ATC ACC GAC ATG ATC GGC GCC ATC AAC GC - #C GGA AAC CCC GGA ATC1008Pro Ile Thr Asp Met Ile Gly Ala Ile Asn Al - #a Gly Asn Pro Gly Ile# 335- GCA CCG CTG TTC GGC CCG GCG ATG TAC GAG AT - #C ACC AAG CTC GGG CTG1056Ala Pro Leu Phe Gly Pro Ala Met Tyr Glu Il - #e Thr Lys Leu Gly Leu# 350- GCC GCG ACG AAT GCC AAC GAC ATC TGG GGC TG - #G TCG AAG GAC GTC CAG1104Ala Ala Thr Asn Ala Asn Asp Ile Trp Gly Tr - #p Ser Lys Asp Val Gln# 365- TTC TAC ATC AAG GCC ACG ACG TTG CGA CTC AC - #C GAG GGC GGC GGC GCC1152Phe Tyr Ile Lys Ala Thr Thr Leu Arg Leu Th - #r Glu Gly Gly Gly Ala# 380- GTC GTC ACG AGC CGC GCC AAC ATC GCG ACC GT - #G ATC AAC GAC TTC ACC1200Val Val Thr Ser Arg Ala Asn Ile Ala Thr Va - #l Ile Asn Asp Phe Thr385 3 - #90 3 - #95 4 -#00- GAG TGG TTC CAC GAG CGC ATC GAG TTC TAC CG - #C GCG AAG GGC GAG TTC1248Glu Trp Phe His Glu Arg Ile Glu Phe Tyr Ar - #g Ala Lys Gly Glu Phe# 415- CCG CTC AAC GGT CCG GTC GAG ATC CGC TGC TG - #C GGG CTC GAT CAG GCA1296Pro Leu Asn Gly Pro Val Glu Ile Arg Cys Cy - #s Gly Leu Asp Gln Ala# 430- GCC GAC GTC AAG GTG CCG TCG GTG GGC CCG CC - #G ACC ATC TCG GCG ACC1344Ala Asp Val Lys Val Pro Ser Val Gly Pro Pr - #o Thr Ile Ser Ala Thr# 445- CGT CCG CGT CCG GAT CAT CCG GAC TGG GAC GT - #C GCG ATC TGG CTG AAC1392Arg Pro Arg Pro Asp His Pro Asp Trp Asp Va - #l Ala Ile Trp Leu Asn# 460- GTT CTC GGT GTT CCG GGC ACC CCC GGC ATG TT - #C GAG TTC TAC CGC GAG1440Val Leu Gly Val Pro Gly Thr Pro Gly Met Ph - #e Glu Phe Tyr Arg Glu465 4 - #70 4 - #75 4 -#80- ATG GAG CAG TGG ATG CGG AGC CAC TAC AAC AA - #C GAC GAC GCC ACC TTC1488Met Glu Gln Trp Met Arg Ser His Tyr Asn As - #n Asp Asp Ala Thr Phe# 495- CGG CCC GAG TGG TCG AAG GGG TGG GCG TTC GG - #T CCC GAC CCG TAC ACC1536Arg Pro Glu Trp Ser Lys Gly Trp Ala Phe Gl - #y Pro Asp Pro Tyr Thr# 510- GAC AAC GAC ATC GTC ACG AAC AAG ATG CGC GC - #C ACC TAC ATC GAA GGT1584Asp Asn Asp Ile Val Thr Asn Lys Met Arg Al - #a Thr Tyr Ile Glu Gly# 525- GTC CCG ACG ACC GAG AAC TGG GAC ACC GCG CG - #C GCT CGG TAC AAC CAG1632Val Pro Thr Thr Glu Asn Trp Asp Thr Ala Ar - #g Ala Arg Tyr Asn Gln# 540- ATC GAC CCG CAT CGC GTG TTC ACC AAC GGA TT - #C ATG GAC AAG CTG CTT1680Ile Asp Pro His Arg Val Phe Thr Asn Gly Ph - #e Met Asp Lys Leu Leu545 5 - #50 5 - #55 5 -#60# 1683Pro- (2) INFORMATION FOR SEQ ID NO: 2:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 561 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein#2: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Ser Thr Gly Pro Val Ala Pro Leu Pro Thr Pr - #o Pro Asn Phe Pro Asn# 15- Asp Ile Ala Leu Phe Gln Gln Ala Tyr Gln As - #n Trp Ser Lys Glu Ile# 30- Met Leu Asp Ala Thr Trp Val Cys Ser Pro Ly - #s Thr Pro Gln Asp Val# 45- Val Arg Leu Ala Asn Trp Ala His Glu His As - #p Tyr Lys Ile Arg Pro# 60- Arg Gly Ala Met His Gly Trp Thr Pro Leu Th - #r Val Glu Lys Gly Ala# 80- Asn Val Glu Lys Val Ile Leu Ala Asp Thr Me - #t Thr His Leu Asn Gly# 95- Ile Thr Val Asn Thr Gly Gly Pro Val Ala Th - #r Val Thr Ala Gly Ala# 110- Gly Ala Ser Ile Glu Ala Ile Val Thr Glu Le - #u Gln Lys His Asp Leu# 125- Gly Trp Ala Asn Leu Pro Ala Pro Gly Val Le - #u Ser Ile Gly Gly Ala# 140- Leu Ala Val Asn Ala His Gly Ala Ala Leu Pr - #o Ala Val Gly Gln Thr145 1 - #50 1 - #55 1 -#60- Thr Leu Pro Gly His Thr Tyr Gly Ser Leu Se - #r Asn Leu Val Thr Glu# 175- Leu Thr Ala Val Val Trp Asn Gly Thr Thr Ty - #r Ala Leu Glu Thr Tyr# 190- Gln Arg Asn Asp Pro Arg Ile Thr Pro Leu Le - #u Thr Asn Leu Gly Arg# 205- Cys Phe Leu Thr Ser Val Thr Met Gln Ala Gl - #y Pro Asn Phe Arg Gln# 220- Arg Cys Gln Ser Tyr Thr Asp Ile Pro Trp Ar - #g Glu Leu Phe Ala Pro225 2 - #30 2 - #35 2 -#40- Lys Gly Ala Asp Gly Arg Thr Phe Glu Lys Ph - #e Val Ala Glu Ser Gly# 255- Gly Ala Glu Ala Ile Trp Tyr Pro Phe Thr Gl - #u Lys Pro Trp Met Lys# 270- Val Trp Thr Val Ser Pro Thr Lys Pro Asp Se - #r Ser Asn Glu Val Gly# 285- Ser Leu Gly Ser Ala Gly Ser Leu Val Gly Ly - #s Pro Pro Gln Ala Arg# 300- Glu Val Ser Gly Pro Tyr Asn Tyr Ile Phe Se - #r Asp Asn Leu Pro Glu305 3 - #10 3 - #15 3 -#20- Pro Ile Thr Asp Met Ile Gly Ala Ile Asn Al - #a Gly Asn Pro Gly Ile# 335- Ala Pro Leu Phe Gly Pro Ala Met Tyr Glu Il - #e Thr Lys Leu Gly Leu# 350- Ala Ala Thr Asn Ala Asn Asp Ile Trp Gly Tr - #p Ser Lys Asp Val Gln# 365- Phe Tyr Ile Lys Ala Thr Thr Leu Arg Leu Th - #r Glu Gly Gly Gly Ala# 380- Val Val Thr Ser Arg Ala Asn Ile Ala Thr Va - #l Ile Asn Asp Phe Thr385 3 - #90 3 - #95 4 -#00- Glu Trp Phe His Glu Arg Ile Glu Phe Tyr Ar - #g Ala Lys Gly Glu Phe# 415- Pro Leu Asn Gly Pro Val Glu Ile Arg Cys Cy - #s Gly Leu Asp Gln Ala# 430- Ala Asp Val Lys Val Pro Ser Val Gly Pro Pr - #o Thr Ile Ser Ala Thr# 445- Arg Pro Arg Pro Asp His Pro Asp Trp Asp Va - #l Ala Ile Trp Leu Asn# 460- Val Leu Gly Val Pro Gly Thr Pro Gly Met Ph - #e Glu Phe Tyr Arg Glu465 4 - #70 4 - #75 4 -#80- Met Glu Gln Trp Met Arg Ser His Tyr Asn As - #n Asp Asp Ala Thr Phe# 495- Arg Pro Glu Trp Ser Lys Gly Trp Ala Phe Gl - #y Pro Asp Pro Tyr Thr# 510- Asp Asn Asp Ile Val Thr Asn Lys Met Arg Al - #a Thr Tyr Ile Glu Gly# 525- Val Pro Thr Thr Glu Asn Trp Asp Thr Ala Ar - #g Ala Arg Tyr Asn Gln# 540- Ile Asp Pro His Arg Val Phe Thr Asn Gly Ph - #e Met Asp Lys Leu Leu545 5 - #50 5 - #55 5 -#60- Pro- (2) INFORMATION FOR SEQ ID NO: 3:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 48 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear#3: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:# 48CGGT CGAGATCCGC TGCTGCGGGC TCGATCAG- (2) INFORMATION FOR SEQ ID NO: 4:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 48 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear#4: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:# 48TTCT CGGTGTTCCG GGCACCCCCG GCATGTTC- (2) INFORMATION FOR SEQ ID NO: 5:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 36 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear#5: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:# 36 CCGA GTGGTCGAAG GGGTGG- (2) INFORMATION FOR SEQ ID NO: 6:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 46 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 17..46#6: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:#TTG CAT GCC 46 ATG ATT ACG CCA AGC#Met Thr Met Ile Thr Pro Ser Leu His Ala# 10- (2) INFORMATION FOR SEQ ID NO: 7:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 10 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein#7: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Thr Met Ile Thr Pro Ser Leu His Ala# 10- (2) INFORMATION FOR SEQ ID NO: 8:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 49 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 20..49#8: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- GAATTTAAGG GGAACATCG ATG ACC ATG ATT ACG CCA AGC - # TTG CAT GCC 49# Met Thr Met Ile Thr Pro Ser Leu His - # Ala# 10- (2) INFORMATION FOR SEQ ID NO: 9:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 10 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein#9: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Thr Met Ile Thr Pro Ser Leu His Ala# 10- (2) INFORMATION FOR SEQ ID NO: 10:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 43 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 20..43#10: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- GAATTTAAGG GGAACATCG ATG AGT AAT CAC CAT GGG CAT - # GCC# 43# Met Ser Asn His His Gly His Ala#5 1- (2) INFORMATION FOR SEQ ID NO: 11:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 8 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein#11: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Ser Asn His His Gly His Ala 1 5- (2) INFORMATION FOR SEQ ID NO: 12:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 45 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 19..45#12: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:#CAT GCC 4 - #5 AAT CAT CAC CAT GGGMet Ser Asn His His His Gly His Ala1 5- (2) INFORMATION FOR SEQ ID NO: 13:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 9 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein#13: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Ser Asn His His His Gly His Ala 1 5- (2) INFORMATION FOR SEQ ID NO: 14:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 58 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 20..58#14: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- GAATTTAAGG GGAACATCG ATG AGT AAT ACG CGT AAA CGC - # AAG CGC CGT ACG 52# Met Ser Asn Thr Arg Lys Arg Lys Arg - # Arg Thr#10# 58His Ala- (2) INFORMATION FOR SEQ ID NO: 15:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 13 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein#15: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Ser Asn Thr Arg Lys Arg Lys Arg Arg Th - #r His Ala# 10- (2) INFORMATION FOR SEQ ID NO: 16:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 48 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 25..48#16: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- GAATTCACAC AGGAAACAGA ATTC ATG GTT ATG CAC CAT G - #GG CAT GCC 48#Gly His Alat Val Met His His# 5 1- (2) INFORMATION FOR SEQ ID NO: 17:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 8 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: protein#17: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Val Met His His Gly His Ala 1 5- (2) INFORMATION FOR SEQ ID NO: 18:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1729 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 17..1729#18: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:#TTG CAT GCC TCG 49 ATG ATT ACG CCA AGC#Met Thr Met Ile Thr Pro Ser Leu His Ala S - #er# 10- ACC GGG CCG GTC GCG CCG CTT CCG ACG CCG CC - #G AAC TTC CCG AAC GAC 97Thr Gly Pro Val Ala Pro Leu Pro Thr Pro Pr - #o Asn Phe Pro Asn Asp# 25- ATC GCG CTG TTC CAG CAG GCG TAC CAG AAC TG - #G TCC AAG GAG ATC ATG 145Ile Ala Leu Phe Gln Gln Ala Tyr Gln Asn Tr - #p Ser Lys Glu Ile Met# 40- CTG GAC GCC ACT TGG GTC TGC TCG CCC AAG AC - #G CCG CAG GAT GTC GTT 193Leu Asp Ala Thr Trp Val Cys Ser Pro Lys Th - #r Pro Gln Asp Val Val# 55- CGC CTT GCC AAC TGG GCG CAC GAG CAC GAC TA - #C AAG ATC CGC CCG CGC 241Arg Leu Ala Asn Trp Ala His Glu His Asp Ty - #r Lys Ile Arg Pro Arg# 75- GGC GCG ATG CAC GGC TGG ACC CCG CTC ACC GT - #G GAG AAG GGG GCC AAC 289Gly Ala Met His Gly Trp Thr Pro Leu Thr Va - #l Glu Lys Gly Ala Asn# 90- GTC GAG AAG GTG ATC CTC GCC GAC ACG ATG AC - #G CAT CTG AAC GGC ATC 337Val Glu Lys Val Ile Leu Ala Asp Thr Met Th - #r His Leu Asn Gly Ile# 105- ACG GTG AAC ACG GGC GGC CCC GTG GCT ACC GT - #C ACC GCC GGT GCC GGC 385Thr Val Asn Thr Gly Gly Pro Val Ala Thr Va - #l Thr Ala Gly Ala Gly# 120- GCC AGC ATC GAG GCG ATC GTC ACC GAA CTG CA - #G AAG CAC GAC CTC GGC 433Ala Ser Ile Glu Ala Ile Val Thr Glu Leu Gl - #n Lys His Asp Leu Gly# 135- TGG GCC AAC CTG CCC GCT CCG GGT GTG CTG TC - #G ATC GGT GGC GCC CTT 481Trp Ala Asn Leu Pro Ala Pro Gly Val Leu Se - #r Ile Gly Gly Ala Leu140 1 - #45 1 - #50 1 -#55- GCG GTC AAC GCG CAC GGT GCG GCG CTG CCG GC - #C GTC GGC CAG ACC ACG 529Ala Val Asn Ala His Gly Ala Ala Leu Pro Al - #a Val Gly Gln Thr Thr# 170- CTG CCC GGT CAC ACC TAC GGT TCG CTG AGC AA - #C CTG GTC ACC GAG CTG 577Leu Pro Gly His Thr Tyr Gly Ser Leu Ser As - #n Leu Val Thr Glu Leu# 185- ACC GCG GTC GTC TGG AAC GGC ACC ACC TAC GC - #A CTC GAG ACG TAC CAG 625Thr Ala Val Val Trp Asn Gly Thr Thr Tyr Al - #a Leu Glu Thr Tyr Gln# 200- CGC AAC GAT CCT CGG ATC ACC CCA CTG CTC AC - #C AAC CTC GGG CGC TGC 673Arg Asn Asp Pro Arg Ile Thr Pro Leu Leu Th - #r Asn Leu Gly Arg Cys# 215- TTC CTG ACC TCG GTG ACG ATG CAG GCC GGC CC - #C AAC TTC CGT CAG CGG 721Phe Leu Thr Ser Val Thr Met Gln Ala Gly Pr - #o Asn Phe Arg Gln Arg220 2 - #25 2 - #30 2 -#35- TGC CAG AGC TAC ACC GAC ATC CCG TGG CGG GA - #A CTG TTC GCG CCG AAG 769Cys Gln Ser Tyr Thr Asp Ile Pro Trp Arg Gl - #u Leu Phe Ala Pro Lys# 250- GGC GCC GAC GGC CGC ACG TTC GAG AAG TTC GT - #C GCG GAA TCG GGC GGC 817Gly Ala Asp Gly Arg Thr Phe Glu Lys Phe Va - #l Ala Glu Ser Gly Gly# 265- GCC GAG GCG ATC TGG TAC CCG TTC ACC GAG AA - #G CCG TGG ATG AAG GTG 865Ala Glu Ala Ile Trp Tyr Pro Phe Thr Glu Ly - #s Pro Trp Met Lys Val# 280- TGG ACG GTC TCG CCG ACC AAG CCG GAC TCG TC - #G AAC GAG GTC GGA AGC 913Trp Thr Val Ser Pro Thr Lys Pro Asp Ser Se - #r Asn Glu Val Gly Ser# 295- CTC GGC TCG GCG GGC TCC CTC GTC GGC AAG CC - #T CCG CAG GCG CGT GAG 961Leu Gly Ser Ala Gly Ser Leu Val Gly Lys Pr - #o Pro Gln Ala Arg Glu300 3 - #05 3 - #10 3 -#15- GTC TCC GGC CCG TAC AAC TAC ATC TTC TCC GA - #C AAC CTG CCG GAG CCC1009Val Ser Gly Pro Tyr Asn Tyr Ile Phe Ser As - #p Asn Leu Pro Glu Pro# 330- ATC ACC GAC ATG ATC GGC GCC ATC AAC GCC GG - #A AAC CCC GGA ATC GCA1057Ile Thr Asp Met Ile Gly Ala Ile Asn Ala Gl - #y Asn Pro Gly Ile Ala# 345- CCG CTG TTC GGC CCG GCG ATG TAC GAG ATC AC - #C AAG CTC GGG CTG GCC1105Pro Leu Phe Gly Pro Ala Met Tyr Glu Ile Th - #r Lys Leu Gly Leu Ala# 360- GCG ACG AAT GCC AAC GAC ATC TGG GGC TGG TC - #G AAG GAC GTC CAG TTC1153Ala Thr Asn Ala Asn Asp Ile Trp Gly Trp Se - #r Lys Asp Val Gln Phe# 375- TAC ATC AAG GCC ACG ACG TTG CGA CTC ACC GA - #G GGC GGC GGC GCC GTC1201Tyr Ile Lys Ala Thr Thr Leu Arg Leu Thr Gl - #u Gly Gly Gly Ala Val380 3 - #85 3 - #90 3 -#95- GTC ACG AGC CGC GCC AAC ATC GCG ACC GTG AT - #C AAC GAC TTC ACC GAG1249Val Thr Ser Arg Ala Asn Ile Ala Thr Val Il - #e Asn Asp Phe Thr Glu# 410- TGG TTC CAC GAG CGC ATC GAG TTC TAC CGC GC - #G AAG GGC GAG TTC CCG1297Trp Phe His Glu Arg Ile Glu Phe Tyr Arg Al - #a Lys Gly Glu Phe Pro# 425- CTC AAC GGT CCG GTC GAG ATC CGC TGC TGC GG - #G CTC GAT CAG GCA GCC1345Leu Asn Gly Pro Val Glu Ile Arg Cys Cys Gl - #y Leu Asp Gln Ala Ala# 440- GAC GTC AAG GTG CCG TCG GTG GGC CCG CCG AC - #C ATC TCG GCG ACC CGT1393Asp Val Lys Val Pro Ser Val Gly Pro Pro Th - #r Ile Ser Ala Thr Arg# 455- CCG CGT CCG GAT CAT CCG GAC TGG GAC GTC GC - #G ATC TGG CTG AAC GTT1441Pro Arg Pro Asp His Pro Asp Trp Asp Val Al - #a Ile Trp Leu Asn Val460 4 - #65 4 - #70 4 -#75- CTC GGT GTT CCG GGC ACC CCC GGC ATG TTC GA - #G TTC TAC CGC GAG ATG1489Leu Gly Val Pro Gly Thr Pro Gly Met Phe Gl - #u Phe Tyr Arg Glu Met# 490- GAG CAG TGG ATG CGG AGC CAC TAC AAC AAC GA - #C GAC GCC ACC TTC CGG1537Glu Gln Trp Met Arg Ser His Tyr Asn Asn As - #p Asp Ala Thr Phe Arg# 505- CCC GAG TGG TCG AAG GGG TGG GCG TTC GGT CC - #C GAC CCG TAC ACC GAC1585Pro Glu Trp Ser Lys Gly Trp Ala Phe Gly Pr - #o Asp Pro Tyr Thr Asp# 520- AAC GAC ATC GTC ACG AAC AAG ATG CGC GCC AC - #C TAC ATC GAA GGT GTC1633Asn Asp Ile Val Thr Asn Lys Met Arg Ala Th - #r Tyr Ile Glu Gly Val# 535- CCG ACG ACC GAG AAC TGG GAC ACC GCG CGC GC - #T CGG TAC AAC CAG ATC1681Pro Thr Thr Glu Asn Trp Asp Thr Ala Arg Al - #a Arg Tyr Asn Gln Ile540 5 - #45 5 - #50 5 -#55- GAC CCG CAT CGC GTG TTC ACC AAC GGA TTC AT - #G GAC AAG CTG CTT CCG1729Asp Pro His Arg Val Phe Thr Asn Gly Phe Me - #t Asp Lys Leu Leu Pro# 570- (2) INFORMATION FOR SEQ ID NO: 19:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 571 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: Protein#19: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Thr Met Ile Thr Pro Ser Leu His Ala Se - #r Thr Gly Pro Val Ala# 15- Pro Leu Pro Thr Pro Pro Asn Phe Pro Asn As - #p Ile Ala Leu Phe Gln# 30- Gln Ala Tyr Gln Asn Trp Ser Lys Glu Ile Me - #t Leu Asp Ala Thr Trp# 45- Val Cys Ser Pro Lys Thr Pro Gln Asp Val Va - #l Arg Leu Ala Asn Trp# 60- Ala His Glu His Asp Tyr Lys Ile Arg Pro Ar - #g Gly Ala Met His Gly# 80- Trp Thr Pro Leu Thr Val Glu Lys Gly Ala As - #n Val Glu Lys Val Ile# 95- Leu Ala Asp Thr Met Thr His Leu Asn Gly Il - #e Thr Val Asn Thr Gly# 110- Gly Pro Val Ala Thr Val Thr Ala Gly Ala Gl - #y Ala Ser Ile Glu Ala# 125- Ile Val Thr Glu Leu Gln Lys His Asp Leu Gl - #y Trp Ala Asn Leu Pro# 140- Ala Pro Gly Val Leu Ser Ile Gly Gly Ala Le - #u Ala Val Asn Ala His145 1 - #50 1 - #55 1 -#60- Gly Ala Ala Leu Pro Ala Val Gly Gln Thr Th - #r Leu Pro Gly His Thr# 175- Tyr Gly Ser Leu Ser Asn Leu Val Thr Glu Le - #u Thr Ala Val Val Trp# 190- Asn Gly Thr Thr Tyr Ala Leu Glu Thr Tyr Gl - #n Arg Asn Asp Pro Arg# 205- Ile Thr Pro Leu Leu Thr Asn Leu Gly Arg Cy - #s Phe Leu Thr Ser Val# 220- Thr Met Gln Ala Gly Pro Asn Phe Arg Gln Ar - #g Cys Gln Ser Tyr Thr225 2 - #30 2 - #35 2 -#40- Asp Ile Pro Trp Arg Glu Leu Phe Ala Pro Ly - #s Gly Ala Asp Gly Arg# 255- Thr Phe Glu Lys Phe Val Ala Glu Ser Gly Gl - #y Ala Glu Ala Ile Trp# 270- Tyr Pro Phe Thr Glu Lys Pro Trp Met Lys Va - #l Trp Thr Val Ser Pro# 285- Thr Lys Pro Asp Ser Ser Asn Glu Val Gly Se - #r Leu Gly Ser Ala Gly# 300- Ser Leu Val Gly Lys Pro Pro Gln Ala Arg Gl - #u Val Ser Gly Pro Tyr305 3 - #10 3 - #15 3 -#20- Asn Tyr Ile Phe Ser Asp Asn Leu Pro Glu Pr - #o Ile Thr Asp Met Ile# 335- Gly Ala Ile Asn Ala Gly Asn Pro Gly Ile Al - #a Pro Leu Phe Gly Pro# 350- Ala Met Tyr Glu Ile Thr Lys Leu Gly Leu Al - #a Ala Thr Asn Ala Asn# 365- Asp Ile Trp Gly Trp Ser Lys Asp Val Gln Ph - #e Tyr Ile Lys Ala Thr# 380- Thr Leu Arg Leu Thr Glu Gly Gly Gly Ala Va - #l Val Thr Ser Arg Ala385 3 - #90 3 - #95 4 -#00- Asn Ile Ala Thr Val Ile Asn Asp Phe Thr Gl - #u Trp Phe His Glu Arg# 415- Ile Glu Phe Tyr Arg Ala Lys Gly Glu Phe Pr - #o Leu Asn Gly Pro Val# 430- Glu Ile Arg Cys Cys Gly Leu Asp Gln Ala Al - #a Asp Val Lys Val Pro# 445- Ser Val Gly Pro Pro Thr Ile Ser Ala Thr Ar - #g Pro Arg Pro Asp His# 460- Pro Asp Trp Asp Val Ala Ile Trp Leu Asn Va - #l Leu Gly Val Pro Gly465 4 - #70 4 - #75 4 -#80- Thr Pro Gly Met Phe Glu Phe Tyr Arg Glu Me - #t Glu Gln Trp Met Arg# 495- Ser His Tyr Asn Asn Asp Asp Ala Thr Phe Ar - #g Pro Glu Trp Ser Lys# 510- Gly Trp Ala Phe Gly Pro Asp Pro Tyr Thr As - #p Asn Asp Ile Val Thr# 525- Asn Lys Met Arg Ala Thr Tyr Ile Glu Gly Va - #l Pro Thr Thr Glu Asn# 540- Trp Asp Thr Ala Arg Ala Arg Tyr Asn Gln Il - #e Asp Pro His Arg Val545 5 - #50 5 - #55 5 -#60- Phe Thr Asn Gly Phe Met Asp Lys Leu Leu Pr - #o# 570- (2) INFORMATION FOR SEQ ID NO: 20:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1732 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 20..1732#20: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- GAATTTAAGG GGAACATCG ATG ACC ATG ATT ACG CCA AGC - # TTG CAT GCC TCG 52Met Thr Met Ile Thr Pro Ser Leu His Ala Se - #r# 10- ACC GGG CCG GTC GCG CCG CTT CCG ACG CCG CC - #G AAC TTC CCG AAC GAC 100Thr Gly Pro Val Ala Pro Leu Pro Thr Pro Pr - #o Asn Phe Pro Asn Asp# 25- ATC GCG CTG TTC CAG CAG GCG TAC CAG AAC TG - #G TCC AAG GAG ATC ATG 148Ile Ala Leu Phe Gln Gln Ala Tyr Gln Asn Tr - #p Ser Lys Glu Ile Met# 40- CTG GAC GCC ACT TGG GTC TGC TCG CCC AAG AC - #G CCG CAG GAT GTC GTT 196Leu Asp Ala Thr Trp Val Cys Ser Pro Lys Th - #r Pro Gln Asp Val Val# 55- CGC CTT GCC AAC TGG GCG CAC GAG CAC GAC TA - #C AAG ATC CGC CCG CGC 244Arg Leu Ala Asn Trp Ala His Glu His Asp Ty - #r Lys Ile Arg Pro Arg# 75- GGC GCG ATG CAC GGC TGG ACC CCG CTC ACC GT - #G GAG AAG GGG GCC AAC 292Gly Ala Met His Gly Trp Thr Pro Leu Thr Va - #l Glu Lys Gly Ala Asn# 90- GTC GAG AAG GTG ATC CTC GCC GAC ACG ATG AC - #G CAT CTG AAC GGC ATC 340Val Glu Lys Val Ile Leu Ala Asp Thr Met Th - #r His Leu Asn Gly Ile# 105- ACG GTG AAC ACG GGC GGC CCC GTG GCT ACC GT - #C ACC GCC GGT GCC GGC 388Thr Val Asn Thr Gly Gly Pro Val Ala Thr Va - #l Thr Ala Gly Ala Gly# 120- GCC AGC ATC GAG GCG ATC GTC ACC GAA CTG CA - #G AAG CAC GAC CTC GGC 436Ala Ser Ile Glu Ala Ile Val Thr Glu Leu Gl - #n Lys His Asp Leu Gly# 135- TGG GCC AAC CTG CCC GCT CCG GGT GTG CTG TC - #G ATC GGT GGC GCC CTT 484Trp Ala Asn Leu Pro Ala Pro Gly Val Leu Se - #r Ile Gly Gly Ala Leu140 1 - #45 1 - #50 1 -#55- GCG GTC AAC GCG CAC GGT GCG GCG CTG CCG GC - #C GTC GGC CAG ACC ACG 532Ala Val Asn Ala His Gly Ala Ala Leu Pro Al - #a Val Gly Gln Thr Thr# 170- CTG CCC GGT CAC ACC TAC GGT TCG CTG AGC AA - #C CTG GTC ACC GAG CTG 580Leu Pro Gly His Thr Tyr Gly Ser Leu Ser As - #n Leu Val Thr Glu Leu# 185- ACC GCG GTC GTC TGG AAC GGC ACC ACC TAC GC - #A CTC GAG ACG TAC CAG 628Thr Ala Val Val Trp Asn Gly Thr Thr Tyr Al - #a Leu Glu Thr Tyr Gln# 200- CGC AAC GAT CCT CGG ATC ACC CCA CTG CTC AC - #C AAC CTC GGG CGC TGC 676Arg Asn Asp Pro Arg Ile Thr Pro Leu Leu Th - #r Asn Leu Gly Arg Cys# 215- TTC CTG ACC TCG GTG ACG ATG CAG GCC GGC CC - #C AAC TTC CGT CAG CGG 724Phe Leu Thr Ser Val Thr Met Gln Ala Gly Pr - #o Asn Phe Arg Gln Arg220 2 - #25 2 - #30 2 -#35- TGC CAG AGC TAC ACC GAC ATC CCG TGG CGG GA - #A CTG TTC GCG CCG AAG 772Cys Gln Ser Tyr Thr Asp Ile Pro Trp Arg Gl - #u Leu Phe Ala Pro Lys# 250- GGC GCC GAC GGC CGC ACG TTC GAG AAG TTC GT - #C GCG GAA TCG GGC GGC 820Gly Ala Asp Gly Arg Thr Phe Glu Lys Phe Va - #l Ala Glu Ser Gly Gly# 265- GCC GAG GCG ATC TGG TAC CCG TTC ACC GAG AA - #G CCG TGG ATG AAG GTG 868Ala Glu Ala Ile Trp Tyr Pro Phe Thr Glu Ly - #s Pro Trp Met Lys Val# 280- TGG ACG GTC TCG CCG ACC AAG CCG GAC TCG TC - #G AAC GAG GTC GGA AGC 916Trp Thr Val Ser Pro Thr Lys Pro Asp Ser Se - #r Asn Glu Val Gly Ser# 295- CTC GGC TCG GCG GGC TCC CTC GTC GGC AAG CC - #T CCG CAG GCG CGT GAG 964Leu Gly Ser Ala Gly Ser Leu Val Gly Lys Pr - #o Pro Gln Ala Arg Glu300 3 - #05 3 - #10 3 -#15- GTC TCC GGC CCG TAC AAC TAC ATC TTC TCC GA - #C AAC CTG CCG GAG CCC1012Val Ser Gly Pro Tyr Asn Tyr Ile Phe Ser As - #p Asn Leu Pro Glu Pro# 330- ATC ACC GAC ATG ATC GGC GCC ATC AAC GCC GG - #A AAC CCC GGA ATC GCA1060Ile Thr Asp Met Ile Gly Ala Ile Asn Ala Gl - #y Asn Pro Gly Ile Ala# 345- CCG CTG TTC GGC CCG GCG ATG TAC GAG ATC AC - #C AAG CTC GGG CTG GCC1108Pro Leu Phe Gly Pro Ala Met Tyr Glu Ile Th - #r Lys Leu Gly Leu Ala# 360- GCG ACG AAT GCC AAC GAC ATC TGG GGC TGG TC - #G AAG GAC GTC CAG TTC1156Ala Thr Asn Ala Asn Asp Ile Trp Gly Trp Se - #r Lys Asp Val Gln Phe# 375- TAC ATC AAG GCC ACG ACG TTG CGA CTC ACC GA - #G GGC GGC GGC GCC GTC1204Tyr Ile Lys Ala Thr Thr Leu Arg Leu Thr Gl - #u Gly Gly Gly Ala Val380 3 - #85 3 - #90 3 -#95- GTC ACG AGC CGC GCC AAC ATC GCG ACC GTG AT - #C AAC GAC TTC ACC GAG1252Val Thr Ser Arg Ala Asn Ile Ala Thr Val Il - #e Asn Asp Phe Thr Glu# 410- TGG TTC CAC GAG CGC ATC GAG TTC TAC CGC GC - #G AAG GGC GAG TTC CCG1300Trp Phe His Glu Arg Ile Glu Phe Tyr Arg Al - #a Lys Gly Glu Phe Pro# 425- CTC AAC GGT CCG GTC GAG ATC CGC TGC TGC GG - #G CTC GAT CAG GCA GCC1348Leu Asn Gly Pro Val Glu Ile Arg Cys Cys Gl - #y Leu Asp Gln Ala Ala# 440- GAC GTC AAG GTG CCG TCG GTG GGC CCG CCG AC - #C ATC TCG GCG ACC CGT1396Asp Val Lys Val Pro Ser Val Gly Pro Pro Th - #r Ile Ser Ala Thr Arg# 455- CCG CGT CCG GAT CAT CCG GAC TGG GAC GTC GC - #G ATC TGG CTG AAC GTT1444Pro Arg Pro Asp His Pro Asp Trp Asp Val Al - #a Ile Trp Leu Asn Val460 4 - #65 4 - #70 4 -#75- CTC GGT GTT CCG GGC ACC CCC GGC ATG TTC GA - #G TTC TAC CGC GAG ATG1492Leu Gly Val Pro Gly Thr Pro Gly Met Phe Gl - #u Phe Tyr Arg Glu Met# 490- GAG CAG TGG ATG CGG AGC CAC TAC AAC AAC GA - #C GAC GCC ACC TTC CGG1540Glu Gln Trp Met Arg Ser His Tyr Asn Asn As - #p Asp Ala Thr Phe Arg# 505- CCC GAG TGG TCG AAG GGG TGG GCG TTC GGT CC - #C GAC CCG TAC ACC GAC1588Pro Glu Trp Ser Lys Gly Trp Ala Phe Gly Pr - #o Asp Pro Tyr Thr Asp# 520- AAC GAC ATC GTC ACG AAC AAG ATG CGC GCC AC - #C TAC ATC GAA GGT GTC1636Asn Asp Ile Val Thr Asn Lys Met Arg Ala Th - #r Tyr Ile Glu Gly Val# 535- CCG ACG ACC GAG AAC TGG GAC ACC GCG CGC GC - #T CGG TAC AAC CAG ATC1684Pro Thr Thr Glu Asn Trp Asp Thr Ala Arg Al - #a Arg Tyr Asn Gln Ile540 5 - #45 5 - #50 5 -#55- GAC CCG CAT CGC GTG TTC ACC AAC GGA TTC AT - #G GAC AAG CTG CTT CCG1732Asp Pro His Arg Val Phe Thr Asn Gly Phe Me - #t Asp Lys Leu Leu Pro# 570- (2) INFORMATION FOR SEQ ID NO: 21:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 571 amino (B) TYPE: amino acids (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: Protein#21: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Thr Met Ile Thr Pro Ser Leu His Ala Se - #r Thr Gly Pro Val Ala# 15- Pro Leu Pro Thr Pro Pro Asn Phe Pro Asn As - #p Ile Ala Leu Phe Gln# 30- Gln Ala Tyr Gln Asn Trp Ser Lys Glu Ile Me - #t Leu Asp Ala Thr Trp# 45- Val Cys Ser Pro Lys Thr Pro Gln Asp Val Va - #l Arg Leu Ala Asn Trp# 60- Ala His Glu His Asp Tyr Lys Ile Arg Pro Ar - #g Gly Ala Met His Gly# 80- Trp Thr Pro Leu Thr Val Glu Lys Gly Ala As - #n Val Glu Lys Val Ile# 95- Leu Ala Asp Thr Met Thr His Leu Asn Gly Il - #e Thr Val Asn Thr Gly# 110- Gly Pro Val Ala Thr Val Thr Ala Gly Ala Gl - #y Ala Ser Ile Glu Ala# 125- Ile Val Thr Glu Leu Gln Lys His Asp Leu Gl - #y Trp Ala Asn Leu Pro# 140- Ala Pro Gly Val Leu Ser Ile Gly Gly Ala Le - #u Ala Val Asn Ala His145 1 - #50 1 - #55 1 -#60- Gly Ala Ala Leu Pro Ala Val Gly Gln Thr Th - #r Leu Pro Gly His Thr# 175- Tyr Gly Ser Leu Ser Asn Leu Val Thr Glu Le - #u Thr Ala Val Val Trp# 190- Asn Gly Thr Thr Tyr Ala Leu Glu Thr Tyr Gl - #n Arg Asn Asp Pro Arg# 205- Ile Thr Pro Leu Leu Thr Asn Leu Gly Arg Cy - #s Phe Leu Thr Ser Val# 220- Thr Met Gln Ala Gly Pro Asn Phe Arg Gln Ar - #g Cys Gln Ser Tyr Thr225 2 - #30 2 - #35 2 -#40- Asp Ile Pro Trp Arg Glu Leu Phe Ala Pro Ly - #s Gly Ala Asp Gly Arg# 255- Thr Phe Glu Lys Phe Val Ala Glu Ser Gly Gl - #y Ala Glu Ala Ile Trp# 270- Tyr Pro Phe Thr Glu Lys Pro Trp Met Lys Va - #l Trp Thr Val Ser Pro# 285- Thr Lys Pro Asp Ser Ser Asn Glu Val Gly Se - #r Leu Gly Ser Ala Gly# 300- Ser Leu Val Gly Lys Pro Pro Gln Ala Arg Gl - #u Val Ser Gly Pro Tyr305 3 - #10 3 - #15 3 -#20- Asn Tyr Ile Phe Ser Asp Asn Leu Pro Glu Pr - #o Ile Thr Asp Met Ile# 335- Gly Ala Ile Asn Ala Gly Asn Pro Gly Ile Al - #a Pro Leu Phe Gly Pro# 350- Ala Met Tyr Glu Ile Thr Lys Leu Gly Leu Al - #a Ala Thr Asn Ala Asn# 365- Asp Ile Trp Gly Trp Ser Lys Asp Val Gln Ph - #e Tyr Ile Lys Ala Thr# 380- Thr Leu Arg Leu Thr Glu Gly Gly Gly Ala Va - #l Val Thr Ser Arg Ala385 3 - #90 3 - #95 4 -#00- Asn Ile Ala Thr Val Ile Asn Asp Phe Thr Gl - #u Trp Phe His Glu Arg# 415- Ile Glu Phe Tyr Arg Ala Lys Gly Glu Phe Pr - #o Leu Asn Gly Pro Val# 430- Glu Ile Arg Cys Cys Gly Leu Asp Gln Ala Al - #a Asp Val Lys Val Pro# 445- Ser Val Gly Pro Pro Thr Ile Ser Ala Thr Ar - #g Pro Arg Pro Asp His# 460- Pro Asp Trp Asp Val Ala Ile Trp Leu Asn Va - #l Leu Gly Val Pro Gly465 4 - #70 4 - #75 4 -#80- Thr Pro Gly Met Phe Glu Phe Tyr Arg Glu Me - #t Glu Gln Trp Met Arg# 495- Ser His Tyr Asn Asn Asp Asp Ala Thr Phe Ar - #g Pro Glu Trp Ser Lys# 510- Gly Trp Ala Phe Gly Pro Asp Pro Tyr Thr As - #p Asn Asp Ile Val Thr# 525- Asn Lys Met Arg Ala Thr Tyr Ile Glu Gly Va - #l Pro Thr Thr Glu Asn# 540- Trp Asp Thr Ala Arg Ala Arg Tyr Asn Gln Il - #e Asp Pro His Arg Val545 5 - #50 5 - #55 5 -#60- Phe Thr Asn Gly Phe Met Asp Lys Leu Leu Pr - #o# 570- (2) INFORMATION FOR SEQ ID NO: 22:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1726 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 20..1726#22: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- GAATTTAAGG GGAACATCG ATG AGT AAT CAC CAT GGG CAT - # GCC TCG ACC GGG 52Met Ser Asn His His Gly His Ala Ser Thr Gl - #y# 10- CCG GTC GCG CCG CTT CCG ACG CCG CCG AAC TT - #C CCG AAC GAC ATC GCG 100Pro Val Ala Pro Leu Pro Thr Pro Pro Asn Ph - #e Pro Asn Asp Ile Ala# 25- CTG TTC CAG CAG GCG TAC CAG AAC TGG TCC AA - #G GAG ATC ATG CTG GAC 148Leu Phe Gln Gln Ala Tyr Gln Asn Trp Ser Ly - #s Glu Ile Met Leu Asp# 40- GCC ACT TGG GTC TGC TCG CCC AAG ACG CCG CA - #G GAT GTC GTT CGC CTT 196Ala Thr Trp Val Cys Ser Pro Lys Thr Pro Gl - #n Asp Val Val Arg Leu# 55- GCC AAC TGG GCG CAC GAG CAC GAC TAC AAG AT - #C CGC CCG CGC GGC GCG 244Ala Asn Trp Ala His Glu His Asp Tyr Lys Il - #e Arg Pro Arg Gly Ala# 75- ATG CAC GGC TGG ACC CCG CTC ACC GTG GAG AA - #G GGG GCC AAC GTC GAG 292Met His Gly Trp Thr Pro Leu Thr Val Glu Ly - #s Gly Ala Asn Val Glu# 90- AAG GTG ATC CTC GCC GAC ACG ATG ACG CAT CT - #G AAC GGC ATC ACG GTG 340Lys Val Ile Leu Ala Asp Thr Met Thr His Le - #u Asn Gly Ile Thr Val# 105- AAC ACG GGC GGC CCC GTG GCT ACC GTC ACC GC - #C GGT GCC GGC GCC AGC 388Asn Thr Gly Gly Pro Val Ala Thr Val Thr Al - #a Gly Ala Gly Ala Ser# 120- ATC GAG GCG ATC GTC ACC GAA CTG CAG AAG CA - #C GAC CTC GGC TGG GCC 436Ile Glu Ala Ile Val Thr Glu Leu Gln Lys Hi - #s Asp Leu Gly Trp Ala# 135- AAC CTG CCC GCT CCG GGT GTG CTG TCG ATC GG - #T GGC GCC CTT GCG GTC 484Asn Leu Pro Ala Pro Gly Val Leu Ser Ile Gl - #y Gly Ala Leu Ala Val140 1 - #45 1 - #50 1 -#55- AAC GCG CAC GGT GCG GCG CTG CCG GCC GTC GG - #C CAG ACC ACG CTG CCC 532Asn Ala His Gly Ala Ala Leu Pro Ala Val Gl - #y Gln Thr Thr Leu Pro# 170- GGT CAC ACC TAC GGT TCG CTG AGC AAC CTG GT - #C ACC GAG CTG ACC GCG 580Gly His Thr Tyr Gly Ser Leu Ser Asn Leu Va - #l Thr Glu Leu Thr Ala# 185- GTC GTC TGG AAC GGC ACC ACC TAC GCA CTC GA - #G ACG TAC CAG CGC AAC 628Val Val Trp Asn Gly Thr Thr Tyr Ala Leu Gl - #u Thr Tyr Gln Arg Asn# 200- GAT CCT CGG ATC ACC CCA CTG CTC ACC AAC CT - #C GGG CGC TGC TTC CTG 676Asp Pro Arg Ile Thr Pro Leu Leu Thr Asn Le - #u Gly Arg Cys Phe Leu# 215- ACC TCG GTG ACG ATG CAG GCC GGC CCC AAC TT - #C CGT CAG CGG TGC CAG 724Thr Ser Val Thr Met Gln Ala Gly Pro Asn Ph - #e Arg Gln Arg Cys Gln220 2 - #25 2 - #30 2 -#35- AGC TAC ACC GAC ATC CCG TGG CGG GAA CTG TT - #C GCG CCG AAG GGC GCC 772Ser Tyr Thr Asp Ile Pro Trp Arg Glu Leu Ph - #e Ala Pro Lys Gly Ala# 250- GAC GGC CGC ACG TTC GAG AAG TTC GTC GCG GA - #A TCG GGC GGC GCC GAG 820Asp Gly Arg Thr Phe Glu Lys Phe Val Ala Gl - #u Ser Gly Gly Ala Glu# 265- GCG ATC TGG TAC CCG TTC ACC GAG AAG CCG TG - #G ATG AAG GTG TGG ACG 868Ala Ile Trp Tyr Pro Phe Thr Glu Lys Pro Tr - #p Met Lys Val Trp Thr# 280- GTC TCG CCG ACC AAG CCG GAC TCG TCG AAC GA - #G GTC GGA AGC CTC GGC 916Val Ser Pro Thr Lys Pro Asp Ser Ser Asn Gl - #u Val Gly Ser Leu Gly# 295- TCG GCG GGC TCC CTC GTC GGC AAG CCT CCG CA - #G GCG CGT GAG GTC TCC 964Ser Ala Gly Ser Leu Val Gly Lys Pro Pro Gl - #n Ala Arg Glu Val Ser300 3 - #05 3 - #10 3 -#15- GGC CCG TAC AAC TAC ATC TTC TCC GAC AAC CT - #G CCG GAG CCC ATC ACC1012Gly Pro Tyr Asn Tyr Ile Phe Ser Asp Asn Le - #u Pro Glu Pro Ile Thr# 330- GAC ATG ATC GGC GCC ATC AAC GCC GGA AAC CC - #C GGA ATC GCA CCG CTG1060Asp Met Ile Gly Ala Ile Asn Ala Gly Asn Pr - #o Gly Ile Ala Pro Leu# 345- TTC GGC CCG GCG ATG TAC GAG ATC ACC AAG CT - #C GGG CTG GCC GCG ACG1108Phe Gly Pro Ala Met Tyr Glu Ile Thr Lys Le - #u Gly Leu Ala Ala Thr# 360- AAT GCC AAC GAC ATC TGG GGC TGG TCG AAG GA - #C GTC CAG TTC TAC ATC1156Asn Ala Asn Asp Ile Trp Gly Trp Ser Lys As - #p Val Gln Phe Tyr Ile# 375- AAG GCC ACG ACG TTG CGA CTC ACC GAG GGC GG - #C GGC GCC GTC GTC ACG1204Lys Ala Thr Thr Leu Arg Leu Thr Glu Gly Gl - #y Gly Ala Val Val Thr380 3 - #85 3 - #90 3 -#95- AGC CGC GCC AAC ATC GCG ACC GTG ATC AAC GA - #C TTC ACC GAG TGG TTC1252Ser Arg Ala Asn Ile Ala Thr Val Ile Asn As - #p Phe Thr Glu Trp Phe# 410- CAC GAG CGC ATC GAG TTC TAC CGC GCG AAG GG - #C GAG TTC CCG CTC AAC1300His Glu Arg Ile Glu Phe Tyr Arg Ala Lys Gl - #y Glu Phe Pro Leu Asn# 425- GGT CCG GTC GAG ATC CGC TGC TGC GGG CTC GA - #T CAG GCA GCC GAC GTC1348Gly Pro Val Glu Ile Arg Cys Cys Gly Leu As - #p Gln Ala Ala Asp Val# 440- AAG GTG CCG TCG GTG GGC CCG CCG ACC ATC TC - #G GCG ACC CGT CCG CGT1396Lys Val Pro Ser Val Gly Pro Pro Thr Ile Se - #r Ala Thr Arg Pro Arg# 455- CCG GAT CAT CCG GAC TGG GAC GTC GCG ATC TG - #G CTG AAC GTT CTC GGT1444Pro Asp His Pro Asp Trp Asp Val Ala Ile Tr - #p Leu Asn Val Leu Gly460 4 - #65 4 - #70 4 -#75- GTT CCG GGC ACC CCC GGC ATG TTC GAG TTC TA - #C CGC GAG ATG GAG CAG1492Val Pro Gly Thr Pro Gly Met Phe Glu Phe Ty - #r Arg Glu Met Glu Gln# 490- TGG ATG CGG AGC CAC TAC AAC AAC GAC GAC GC - #C ACC TTC CGG CCC GAG1540Trp Met Arg Ser His Tyr Asn Asn Asp Asp Al - #a Thr Phe Arg Pro Glu# 505- TGG TCG AAG GGG TGG GCG TTC GGT CCC GAC CC - #G TAC ACC GAC AAC GAC1588Trp Ser Lys Gly Trp Ala Phe Gly Pro Asp Pr - #o Tyr Thr Asp Asn Asp# 520- ATC GTC ACG AAC AAG ATG CGC GCC ACC TAC AT - #C GAA GGT GTC CCG ACG1636Ile Val Thr Asn Lys Met Arg Ala Thr Tyr Il - #e Glu Gly Val Pro Thr# 535- ACC GAG AAC TGG GAC ACC GCG CGC GCT CGG TA - #C AAC CAG ATC GAC CCG1684Thr Glu Asn Trp Asp Thr Ala Arg Ala Arg Ty - #r Asn Gln Ile Asp Pro540 5 - #45 5 - #50 5 -#55- CAT CGC GTG TTC ACC AAC GGA TTC ATG GAC AA - #G CTG CTT CCG#1726His Arg Val Phe Thr Asn Gly Phe Met Asp Ly - #s Leu Leu Pro# 565- (2) INFORMATION FOR SEQ ID NO: 23:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 569 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: Protein#23: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Ser Asn His His Gly His Ala Ser Thr Gl - #y Pro Val Ala Pro Leu# 15- Pro Thr Pro Pro Asn Phe Pro Asn Asp Ile Al - #a Leu Phe Gln Gln Ala# 30- Tyr Gln Asn Trp Ser Lys Glu Ile Met Leu As - #p Ala Thr Trp Val Cys# 45- Ser Pro Lys Thr Pro Gln Asp Val Val Arg Le - #u Ala Asn Trp Ala His# 60- Glu His Asp Tyr Lys Ile Arg Pro Arg Gly Al - #a Met His Gly Trp Thr# 80- Pro Leu Thr Val Glu Lys Gly Ala Asn Val Gl - #u Lys Val Ile Leu Ala# 95- Asp Thr Met Thr His Leu Asn Gly Ile Thr Va - #l Asn Thr Gly Gly Pro# 110- Val Ala Thr Val Thr Ala Gly Ala Gly Ala Se - #r Ile Glu Ala Ile Val# 125- Thr Glu Leu Gln Lys His Asp Leu Gly Trp Al - #a Asn Leu Pro Ala Pro# 140- Gly Val Leu Ser Ile Gly Gly Ala Leu Ala Va - #l Asn Ala His Gly Ala145 1 - #50 1 - #55 1 -#60- Ala Leu Pro Ala Val Gly Gln Thr Thr Leu Pr - #o Gly His Thr Tyr Gly# 175- Ser Leu Ser Asn Leu Val Thr Glu Leu Thr Al - #a Val Val Trp Asn Gly# 190- Thr Thr Tyr Ala Leu Glu Thr Tyr Gln Arg As - #n Asp Pro Arg Ile Thr# 205- Pro Leu Leu Thr Asn Leu Gly Arg Cys Phe Le - #u Thr Ser Val Thr Met# 220- Gln Ala Gly Pro Asn Phe Arg Gln Arg Cys Gl - #n Ser Tyr Thr Asp Ile225 2 - #30 2 - #35 2 -#40- Pro Trp Arg Glu Leu Phe Ala Pro Lys Gly Al - #a Asp Gly Arg Thr Phe# 255- Glu Lys Phe Val Ala Glu Ser Gly Gly Ala Gl - #u Ala Ile Trp Tyr Pro# 270- Phe Thr Glu Lys Pro Trp Met Lys Val Trp Th - #r Val Ser Pro Thr Lys# 285- Pro Asp Ser Ser Asn Glu Val Gly Ser Leu Gl - #y Ser Ala Gly Ser Leu# 300- Val Gly Lys Pro Pro Gln Ala Arg Glu Val Se - #r Gly Pro Tyr Asn Tyr305 3 - #10 3 - #15 3 -#20- Ile Phe Ser Asp Asn Leu Pro Glu Pro Ile Th - #r Asp Met Ile Gly Ala# 335- Ile Asn Ala Gly Asn Pro Gly Ile Ala Pro Le - #u Phe Gly Pro Ala Met# 350- Tyr Glu Ile Thr Lys Leu Gly Leu Ala Ala Th - #r Asn Ala Asn Asp Ile# 365- Trp Gly Trp Ser Lys Asp Val Gln Phe Tyr Il - #e Lys Ala Thr Thr Leu# 380- Arg Leu Thr Glu Gly Gly Gly Ala Val Val Th - #r Ser Arg Ala Asn Ile385 3 - #90 3 - #95 4 -#00- Ala Thr Val Ile Asn Asp Phe Thr Glu Trp Ph - #e His Glu Arg Ile Glu# 415- Phe Tyr Arg Ala Lys Gly Glu Phe Pro Leu As - #n Gly Pro Val Glu Ile# 430- Arg Cys Cys Gly Leu Asp Gln Ala Ala Asp Va - #l Lys Val Pro Ser Val# 445- Gly Pro Pro Thr Ile Ser Ala Thr Arg Pro Ar - #g Pro Asp His Pro Asp# 460- Trp Asp Val Ala Ile Trp Leu Asn Val Leu Gl - #y Val Pro Gly Thr Pro465 4 - #70 4 - #75 4 -#80- Gly Met Phe Glu Phe Tyr Arg Glu Met Glu Gl - #n Trp Met Arg Ser His# 495- Tyr Asn Asn Asp Asp Ala Thr Phe Arg Pro Gl - #u Trp Ser Lys Gly Trp# 510- Ala Phe Gly Pro Asp Pro Tyr Thr Asp Asn As - #p Ile Val Thr Asn Lys# 525- Met Arg Ala Thr Tyr Ile Glu Gly Val Pro Th - #r Thr Glu Asn Trp Asp# 540- Thr Ala Arg Ala Arg Tyr Asn Gln Ile Asp Pr - #o His Arg Val Phe Thr545 5 - #50 5 - #55 5 -#60- Asn Gly Phe Met Asp Lys Leu Leu Pro 565- (2) INFORMATION FOR SEQ ID NO: 24:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1728 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 19..1728#24: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:#CAT GCC TCG ACC 51 AGT AAT CAT CAC CAT GGGMet Ser Asn His His His Gly His Ala Ser Th - #r# 10- GGG CCG GTC GCG CCG CTT CCG ACG CCG CCG AA - #C TTC CCG AAC GAC ATC 99Gly Pro Val Ala Pro Leu Pro Thr Pro Pro As - #n Phe Pro Asn Asp Ile# 25- GCG CTG TTC CAG CAG GCG TAC CAG AAC TGG TC - #C AAG GAG ATC ATG CTG 147Ala Leu Phe Gln Gln Ala Tyr Gln Asn Trp Se - #r Lys Glu Ile Met Leu# 40- GAC GCC ACT TGG GTC TGC TCG CCC AAG ACG CC - #G CAG GAT GTC GTT CGC 195Asp Ala Thr Trp Val Cys Ser Pro Lys Thr Pr - #o Gln Asp Val Val Arg# 55- CTT GCC AAC TGG GCG CAC GAG CAC GAC TAC AA - #G ATC CGC CCG CGC GGC 243Leu Ala Asn Trp Ala His Glu His Asp Tyr Ly - #s Ile Arg Pro Arg Gly# 75- GCG ATG CAC GGC TGG ACC CCG CTC ACC GTG GA - #G AAG GGG GCC AAC GTC 291Ala Met His Gly Trp Thr Pro Leu Thr Val Gl - #u Lys Gly Ala Asn Val# 90- GAG AAG GTG ATC CTC GCC GAC ACG ATG ACG CA - #T CTG AAC GGC ATC ACG 339Glu Lys Val Ile Leu Ala Asp Thr Met Thr Hi - #s Leu Asn Gly Ile Thr# 105- GTG AAC ACG GGC GGC CCC GTG GCT ACC GTC AC - #C GCC GGT GCC GGC GCC 387Val Asn Thr Gly Gly Pro Val Ala Thr Val Th - #r Ala Gly Ala Gly Ala# 120- AGC ATC GAG GCG ATC GTC ACC GAA CTG CAG AA - #G CAC GAC CTC GGC TGG 435Ser Ile Glu Ala Ile Val Thr Glu Leu Gln Ly - #s His Asp Leu Gly Trp# 135- GCC AAC CTG CCC GCT CCG GGT GTG CTG TCG AT - #C GGT GGC GCC CTT GCG 483Ala Asn Leu Pro Ala Pro Gly Val Leu Ser Il - #e Gly Gly Ala Leu Ala140 1 - #45 1 - #50 1 -#55- GTC AAC GCG CAC GGT GCG GCG CTG CCG GCC GT - #C GGC CAG ACC ACG CTG 531Val Asn Ala His Gly Ala Ala Leu Pro Ala Va - #l Gly Gln Thr Thr Leu# 170- CCC GGT CAC ACC TAC GGT TCG CTG AGC AAC CT - #G GTC ACC GAG CTG ACC 579Pro Gly His Thr Tyr Gly Ser Leu Ser Asn Le - #u Val Thr Glu Leu Thr# 185- GCG GTC GTC TGG AAC GGC ACC ACC TAC GCA CT - #C GAG ACG TAC CAG CGC 627Ala Val Val Trp Asn Gly Thr Thr Tyr Ala Le - #u Glu Thr Tyr Gln Arg# 200- AAC GAT CCT CGG ATC ACC CCA CTG CTC ACC AA - #C CTC GGG CGC TGC TTC 675Asn Asp Pro Arg Ile Thr Pro Leu Leu Thr As - #n Leu Gly Arg Cys Phe# 215- CTG ACC TCG GTG ACG ATG CAG GCC GGC CCC AA - #C TTC CGT CAG CGG TGC 723Leu Thr Ser Val Thr Met Gln Ala Gly Pro As - #n Phe Arg Gln Arg Cys220 2 - #25 2 - #30 2 -#35- CAG AGC TAC ACC GAC ATC CCG TGG CGG GAA CT - #G TTC GCG CCG AAG GGC 771Gln Ser Tyr Thr Asp Ile Pro Trp Arg Glu Le - #u Phe Ala Pro Lys Gly# 250- GCC GAC GGC CGC ACG TTC GAG AAG TTC GTC GC - #G GAA TCG GGC GGC GCC 819Ala Asp Gly Arg Thr Phe Glu Lys Phe Val Al - #a Glu Ser Gly Gly Ala# 265- GAG GCG ATC TGG TAC CCG TTC ACC GAG AAG CC - #G TGG ATG AAG GTG TGG 867Glu Ala Ile Trp Tyr Pro Phe Thr Glu Lys Pr - #o Trp Met Lys Val Trp# 280- ACG GTC TCG CCG ACC AAG CCG GAC TCG TCG AA - #C GAG GTC GGA AGC CTC 915Thr Val Ser Pro Thr Lys Pro Asp Ser Ser As - #n Glu Val Gly Ser Leu# 295- GGC TCG GCG GGC TCC CTC GTC GGC AAG CCT CC - #G CAG GCG CGT GAG GTC 963Gly Ser Ala Gly Ser Leu Val Gly Lys Pro Pr - #o Gln Ala Arg Glu Val300 3 - #05 3 - #10 3 -#15- TCC GGC CCG TAC AAC TAC ATC TTC TCC GAC AA - #C CTG CCG GAG CCC ATC1011Ser Gly Pro Tyr Asn Tyr Ile Phe Ser Asp As - #n Leu Pro Glu Pro Ile# 330- ACC GAC ATG ATC GGC GCC ATC AAC GCC GGA AA - #C CCC GGA ATC GCA CCG1059Thr Asp Met Ile Gly Ala Ile Asn Ala Gly As - #n Pro Gly Ile Ala Pro# 345- CTG TTC GGC CCG GCG ATG TAC GAG ATC ACC AA - #G CTC GGG CTG GCC GCG1107Leu Phe Gly Pro Ala Met Tyr Glu Ile Thr Ly - #s Leu Gly Leu Ala Ala# 360- ACG AAT GCC AAC GAC ATC TGG GGC TGG TCG AA - #G GAC GTC CAG TTC TAC1155Thr Asn Ala Asn Asp Ile Trp Gly Trp Ser Ly - #s Asp Val Gln Phe Tyr# 375- ATC AAG GCC ACG ACG TTG CGA CTC ACC GAG GG - #C GGC GGC GCC GTC GTC1203Ile Lys Ala Thr Thr Leu Arg Leu Thr Glu Gl - #y Gly Gly Ala Val Val380 3 - #85 3 - #90 3 -#95- ACG AGC CGC GCC AAC ATC GCG ACC GTG ATC AA - #C GAC TTC ACC GAG TGG1251Thr Ser Arg Ala Asn Ile Ala Thr Val Ile As - #n Asp Phe Thr Glu Trp# 410- TTC CAC GAG CGC ATC GAG TTC TAC CGC GCG AA - #G GGC GAG TTC CCG CTC1299Phe His Glu Arg Ile Glu Phe Tyr Arg Ala Ly - #s Gly Glu Phe Pro Leu# 425- AAC GGT CCG GTC GAG ATC CGC TGC TGC GGG CT - #C GAT CAG GCA GCC GAC1347Asn Gly Pro Val Glu Ile Arg Cys Cys Gly Le - #u Asp Gln Ala Ala Asp# 440- GTC AAG GTG CCG TCG GTG GGC CCG CCG ACC AT - #C TCG GCG ACC CGT CCG1395Val Lys Val Pro Ser Val Gly Pro Pro Thr Il - #e Ser Ala Thr Arg Pro# 455- CGT CCG GAT CAT CCG GAC TGG GAC GTC GCG AT - #C TGG CTG AAC GTT CTC1443Arg Pro Asp His Pro Asp Trp Asp Val Ala Il - #e Trp Leu Asn Val Leu460 4 - #65 4 - #70 4 -#75- GGT GTT CCG GGC ACC CCC GGC ATG TTC GAG TT - #C TAC CGC GAG ATG GAG1491Gly Val Pro Gly Thr Pro Gly Met Phe Glu Ph - #e Tyr Arg Glu Met Glu# 490- CAG TGG ATG CGG AGC CAC TAC AAC AAC GAC GA - #C GCC ACC TTC CGG CCC1539Gln Trp Met Arg Ser His Tyr Asn Asn Asp As - #p Ala Thr Phe Arg Pro# 505- GAG TGG TCG AAG GGG TGG GCG TTC GGT CCC GA - #C CCG TAC ACC GAC AAC1587Glu Trp Ser Lys Gly Trp Ala Phe Gly Pro As - #p Pro Tyr Thr Asp Asn# 520- GAC ATC GTC ACG AAC AAG ATG CGC GCC ACC TA - #C ATC GAA GGT GTC CCG1635Asp Ile Val Thr Asn Lys Met Arg Ala Thr Ty - #r Ile Glu Gly Val Pro# 535- ACG ACC GAG AAC TGG GAC ACC GCG CGC GCT CG - #G TAC AAC CAG ATC GAC1683Thr Thr Glu Asn Trp Asp Thr Ala Arg Ala Ar - #g Tyr Asn Gln Ile Asp540 5 - #45 5 - #50 5 -#55- CCG CAT CGC GTG TTC ACC AAC GGA TTC ATG GA - #C AAG CTG CTT CCG1728Pro His Arg Val Phe Thr Asn Gly Phe Met As - #p Lys Leu Leu Pro# 570- (2) INFORMATION FOR SEQ ID NO: 25:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 570 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: Protein#25: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Ser Asn His His His Gly His Ala Ser Th - #r Gly Pro Val Ala Pro# 15- Leu Pro Thr Pro Pro Asn Phe Pro Asn Asp Il - #e Ala Leu Phe Gln Gln# 30- Ala Tyr Gln Asn Trp Ser Lys Glu Ile Met Le - #u Asp Ala Thr Trp Val# 45- Cys Ser Pro Lys Thr Pro Gln Asp Val Val Ar - #g Leu Ala Asn Trp Ala# 60- His Glu His Asp Tyr Lys Ile Arg Pro Arg Gl - #y Ala Met His Gly Trp# 80- Thr Pro Leu Thr Val Glu Lys Gly Ala Asn Va - #l Glu Lys Val Ile Leu# 95- Ala Asp Thr Met Thr His Leu Asn Gly Ile Th - #r Val Asn Thr Gly Gly# 110- Pro Val Ala Thr Val Thr Ala Gly Ala Gly Al - #a Ser Ile Glu Ala Ile# 125- Val Thr Glu Leu Gln Lys His Asp Leu Gly Tr - #p Ala Asn Leu Pro Ala# 140- Pro Gly Val Leu Ser Ile Gly Gly Ala Leu Al - #a Val Asn Ala His Gly145 1 - #50 1 - #55 1 -#60- Ala Ala Leu Pro Ala Val Gly Gln Thr Thr Le - #u Pro Gly His Thr Tyr# 175- Gly Ser Leu Ser Asn Leu Val Thr Glu Leu Th - #r Ala Val Val Trp Asn# 190- Gly Thr Thr Tyr Ala Leu Glu Thr Tyr Gln Ar - #g Asn Asp Pro Arg Ile# 205- Thr Pro Leu Leu Thr Asn Leu Gly Arg Cys Ph - #e Leu Thr Ser Val Thr# 220- Met Gln Ala Gly Pro Asn Phe Arg Gln Arg Cy - #s Gln Ser Tyr Thr Asp225 2 - #30 2 - #35 2 -#40- Ile Pro Trp Arg Glu Leu Phe Ala Pro Lys Gl - #y Ala Asp Gly Arg Thr# 255- Phe Glu Lys Phe Val Ala Glu Ser Gly Gly Al - #a Glu Ala Ile Trp Tyr# 270- Pro Phe Thr Glu Lys Pro Trp Met Lys Val Tr - #p Thr Val Ser Pro Thr# 285- Lys Pro Asp Ser Ser Asn Glu Val Gly Ser Le - #u Gly Ser Ala Gly Ser# 300- Leu Val Gly Lys Pro Pro Gln Ala Arg Glu Va - #l Ser Gly Pro Tyr Asn305 3 - #10 3 - #15 3 -#20- Tyr Ile Phe Ser Asp Asn Leu Pro Glu Pro Il - #e Thr Asp Met Ile Gly# 335- Ala Ile Asn Ala Gly Asn Pro Gly Ile Ala Pr - #o Leu Phe Gly Pro Ala# 350- Met Tyr Glu Ile Thr Lys Leu Gly Leu Ala Al - #a Thr Asn Ala Asn Asp# 365- Ile Trp Gly Trp Ser Lys Asp Val Gln Phe Ty - #r Ile Lys Ala Thr Thr# 380- Leu Arg Leu Thr Glu Gly Gly Gly Ala Val Va - #l Thr Ser Arg Ala Asn385 3 - #90 3 - #95 4 -#00- Ile Ala Thr Val Ile Asn Asp Phe Thr Glu Tr - #p Phe His Glu Arg Ile# 415- Glu Phe Tyr Arg Ala Lys Gly Glu Phe Pro Le - #u Asn Gly Pro Val Glu# 430- Ile Arg Cys Cys Gly Leu Asp Gln Ala Ala As - #p Val Lys Val Pro Ser# 445- Val Gly Pro Pro Thr Ile Ser Ala Thr Arg Pr - #o Arg Pro Asp His Pro# 460- Asp Trp Asp Val Ala Ile Trp Leu Asn Val Le - #u Gly Val Pro Gly Thr465 4 - #70 4 - #75 4 -#80- Pro Gly Met Phe Glu Phe Tyr Arg Glu Met Gl - #u Gln Trp Met Arg Ser# 495- His Tyr Asn Asn Asp Asp Ala Thr Phe Arg Pr - #o Glu Trp Ser Lys Gly# 510- Trp Ala Phe Gly Pro Asp Pro Tyr Thr Asp As - #n Asp Ile Val Thr Asn# 525- Lys Met Arg Ala Thr Tyr Ile Glu Gly Val Pr - #o Thr Thr Glu Asn Trp# 540- Asp Thr Ala Arg Ala Arg Tyr Asn Gln Ile As - #p Pro His Arg Val Phe545 5 - #50 5 - #55 5 -#60- Thr Asn Gly Phe Met Asp Lys Leu Leu Pro# 570- (2) INFORMATION FOR SEQ ID NO: 26:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1741 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 20..1741#26: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- GAATTTAAGG GGAACATCG ATG AGT AAT ACG CGT AAA CGC - # AAG CGC CGT ACG 52Met Ser Asn Thr Arg Lys Arg Lys Arg Arg Th - #r# 10- CAT GCC TCG ACC GGG CCG GTC GCG CCG CTT CC - #G ACG CCG CCG AAC TTC 100His Ala Ser Thr Gly Pro Val Ala Pro Leu Pr - #o Thr Pro Pro Asn Phe# 25- CCG AAC GAC ATC GCG CTG TTC CAG CAG GCG TA - #C CAG AAC TGG TCC AAG 148Pro Asn Asp Ile Ala Leu Phe Gln Gln Ala Ty - #r Gln Asn Trp Ser Lys# 40- GAG ATC ATG CTG GAC GCC ACT TGG GTC TGC TC - #G CCC AAG ACG CCG CAG 196Glu Ile Met Leu Asp Ala Thr Trp Val Cys Se - #r Pro Lys Thr Pro Gln# 55- GAT GTC GTT CGC CTT GCC AAC TGG GCG CAC GA - #G CAC GAC TAC AAG ATC 244Asp Val Val Arg Leu Ala Asn Trp Ala His Gl - #u His Asp Tyr Lys Ile# 75- CGC CCG CGC GGC GCG ATG CAC GGC TGG ACC CC - #G CTC ACC GTG GAG AAG 292Arg Pro Arg Gly Ala Met His Gly Trp Thr Pr - #o Leu Thr Val Glu Lys# 90- GGG GCC AAC GTC GAG AAG GTG ATC CTC GCC GA - #C ACG ATG ACG CAT CTG 340Gly Ala Asn Val Glu Lys Val Ile Leu Ala As - #p Thr Met Thr His Leu# 105- AAC GGC ATC ACG GTG AAC ACG GGC GGC CCC GT - #G GCT ACC GTC ACC GCC 388Asn Gly Ile Thr Val Asn Thr Gly Gly Pro Va - #l Ala Thr Val Thr Ala# 120- GGT GCC GGC GCC AGC ATC GAG GCG ATC GTC AC - #C GAA CTG CAG AAG CAC 436Gly Ala Gly Ala Ser Ile Glu Ala Ile Val Th - #r Glu Leu Gln Lys His# 135- GAC CTC GGC TGG GCC AAC CTG CCC GCT CCG GG - #T GTG CTG TCG ATC GGT 484Asp Leu Gly Trp Ala Asn Leu Pro Ala Pro Gl - #y Val Leu Ser Ile Gly140 1 - #45 1 - #50 1 -#55- GGC GCC CTT GCG GTC AAC GCG CAC GGT GCG GC - #G CTG CCG GCC GTC GGC 532Gly Ala Leu Ala Val Asn Ala His Gly Ala Al - #a Leu Pro Ala Val Gly# 170- CAG ACC ACG CTG CCC GGT CAC ACC TAC GGT TC - #G CTG AGC AAC CTG GTC 580Gln Thr Thr Leu Pro Gly His Thr Tyr Gly Se - #r Leu Ser Asn Leu Val# 185- ACC GAG CTG ACC GCG GTC GTC TGG AAC GGC AC - #C ACC TAC GCA CTC GAG 628Thr Glu Leu Thr Ala Val Val Trp Asn Gly Th - #r Thr Tyr Ala Leu Glu# 200- ACG TAC CAG CGC AAC GAT CCT CGG ATC ACC CC - #A CTG CTC ACC AAC CTC 676Thr Tyr Gln Arg Asn Asp Pro Arg Ile Thr Pr - #o Leu Leu Thr Asn Leu# 215- GGG CGC TGC TTC CTG ACC TCG GTG ACG ATG CA - #G GCC GGC CCC AAC TTC 724Gly Arg Cys Phe Leu Thr Ser Val Thr Met Gl - #n Ala Gly Pro Asn Phe220 2 - #25 2 - #30 2 -#35- CGT CAG CGG TGC CAG AGC TAC ACC GAC ATC CC - #G TGG CGG GAA CTG TTC 772Arg Gln Arg Cys Gln Ser Tyr Thr Asp Ile Pr - #o Trp Arg Glu Leu Phe# 250- GCG CCG AAG GGC GCC GAC GGC CGC ACG TTC GA - #G AAG TTC GTC GCG GAA 820Ala Pro Lys Gly Ala Asp Gly Arg Thr Phe Gl - #u Lys Phe Val Ala Glu# 265- TCG GGC GGC GCC GAG GCG ATC TGG TAC CCG TT - #C ACC GAG AAG CCG TGG 868Ser Gly Gly Ala Glu Ala Ile Trp Tyr Pro Ph - #e Thr Glu Lys Pro Trp# 280- ATG AAG GTG TGG ACG GTC TCG CCG ACC AAG CC - #G GAC TCG TCG AAC GAG 916Met Lys Val Trp Thr Val Ser Pro Thr Lys Pr - #o Asp Ser Ser Asn Glu# 295- GTC GGA AGC CTC GGC TCG GCG GGC TCC CTC GT - #C GGC AAG CCT CCG CAG 964Val Gly Ser Leu Gly Ser Ala Gly Ser Leu Va - #l Gly Lys Pro Pro Gln300 3 - #05 3 - #10 3 -#15- GCG CGT GAG GTC TCC GGC CCG TAC AAC TAC AT - #C TTC TCC GAC AAC CTG1012Ala Arg Glu Val Ser Gly Pro Tyr Asn Tyr Il - #e Phe Ser Asp Asn Leu# 330- CCG GAG CCC ATC ACC GAC ATG ATC GGC GCC AT - #C AAC GCC GGA AAC CCC1060Pro Glu Pro Ile Thr Asp Met Ile Gly Ala Il - #e Asn Ala Gly Asn Pro# 345- GGA ATC GCA CCG CTG TTC GGC CCG GCG ATG TA - #C GAG ATC ACC AAG CTC1108Gly Ile Ala Pro Leu Phe Gly Pro Ala Met Ty - #r Glu Ile Thr Lys Leu# 360- GGG CTG GCC GCG ACG AAT GCC AAC GAC ATC TG - #G GGC TGG TCG AAG GAC1156Gly Leu Ala Ala Thr Asn Ala Asn Asp Ile Tr - #p Gly Trp Ser Lys Asp# 375- GTC CAG TTC TAC ATC AAG GCC ACG ACG TTG CG - #A CTC ACC GAG GGC GGC1204Val Gln Phe Tyr Ile Lys Ala Thr Thr Leu Ar - #g Leu Thr Glu Gly Gly380 3 - #85 3 - #90 3 -#95- GGC GCC GTC GTC ACG AGC CGC GCC AAC ATC GC - #G ACC GTG ATC AAC GAC1252Gly Ala Val Val Thr Ser Arg Ala Asn Ile Al - #a Thr Val Ile Asn Asp# 410- TTC ACC GAG TGG TTC CAC GAG CGC ATC GAG TT - #C TAC CGC GCG AAG GGC1300Phe Thr Glu Trp Phe His Glu Arg Ile Glu Ph - #e Tyr Arg Ala Lys Gly# 425- GAG TTC CCG CTC AAC GGT CCG GTC GAG ATC CG - #C TGC TGC GGG CTC GAT1348Glu Phe Pro Leu Asn Gly Pro Val Glu Ile Ar - #g Cys Cys Gly Leu Asp# 440- CAG GCA GCC GAC GTC AAG GTG CCG TCG GTG GG - #C CCG CCG ACC ATC TCG1396Gln Ala Ala Asp Val Lys Val Pro Ser Val Gl - #y Pro Pro Thr Ile Ser# 455- GCG ACC CGT CCG CGT CCG GAT CAT CCG GAC TG - #G GAC GTC GCG ATC TGG1444Ala Thr Arg Pro Arg Pro Asp His Pro Asp Tr - #p Asp Val Ala Ile Trp460 4 - #65 4 - #70 4 -#75- CTG AAC GTT CTC GGT GTT CCG GGC ACC CCC GG - #C ATG TTC GAG TTC TAC1492Leu Asn Val Leu Gly Val Pro Gly Thr Pro Gl - #y Met Phe Glu Phe Tyr# 490- CGC GAG ATG GAG CAG TGG ATG CGG AGC CAC TA - #C AAC AAC GAC GAC GCC1540Arg Glu Met Glu Gln Trp Met Arg Ser His Ty - #r Asn Asn Asp Asp Ala# 505- ACC TTC CGG CCC GAG TGG TCG AAG GGG TGG GC - #G TTC GGT CCC GAC CCG1588Thr Phe Arg Pro Glu Trp Ser Lys Gly Trp Al - #a Phe Gly Pro Asp Pro# 520- TAC ACC GAC AAC GAC ATC GTC ACG AAC AAG AT - #G CGC GCC ACC TAC ATC1636Tyr Thr Asp Asn Asp Ile Val Thr Asn Lys Me - #t Arg Ala Thr Tyr Ile# 535- GAA GGT GTC CCG ACG ACC GAG AAC TGG GAC AC - #C GCG CGC GCT CGG TAC1684Glu Gly Val Pro Thr Thr Glu Asn Trp Asp Th - #r Ala Arg Ala Arg Tyr540 5 - #45 5 - #50 5 -#55- AAC CAG ATC GAC CCG CAT CGC GTG TTC ACC AA - #C GGA TTC ATG GAC AAG1732Asn Gln Ile Asp Pro His Arg Val Phe Thr As - #n Gly Phe Met Asp Lys# 570# 1741Leu Leu Pro- (2) INFORMATION FOR SEQ ID NO: 27:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 574 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: Protein#27: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Ser Asn Thr Arg Lys Arg Lys Arg Arg Th - #r His Ala Ser Thr Gly# 15- Pro Val Ala Pro Leu Pro Thr Pro Pro Asn Ph - #e Pro Asn Asp Ile Ala# 30- Leu Phe Gln Gln Ala Tyr Gln Asn Trp Ser Ly - #s Glu Ile Met Leu Asp# 45- Ala Thr Trp Val Cys Ser Pro Lys Thr Pro Gl - #n Asp Val Val Arg Leu# 60- Ala Asn Trp Ala His Glu His Asp Tyr Lys Il - #e Arg Pro Arg Gly Ala# 80- Met His Gly Trp Thr Pro Leu Thr Val Glu Ly - #s Gly Ala Asn Val Glu# 95- Lys Val Ile Leu Ala Asp Thr Met Thr His Le - #u Asn Gly Ile Thr Val# 110- Asn Thr Gly Gly Pro Val Ala Thr Val Thr Al - #a Gly Ala Gly Ala Ser# 125- Ile Glu Ala Ile Val Thr Glu Leu Gln Lys Hi - #s Asp Leu Gly Trp Ala# 140- Asn Leu Pro Ala Pro Gly Val Leu Ser Ile Gl - #y Gly Ala Leu Ala Val145 1 - #50 1 - #55 1 -#60- Asn Ala His Gly Ala Ala Leu Pro Ala Val Gl - #y Gln Thr Thr Leu Pro# 175- Gly His Thr Tyr Gly Ser Leu Ser Asn Leu Va - #l Thr Glu Leu Thr Ala# 190- Val Val Trp Asn Gly Thr Thr Tyr Ala Leu Gl - #u Thr Tyr Gln Arg Asn# 205- Asp Pro Arg Ile Thr Pro Leu Leu Thr Asn Le - #u Gly Arg Cys Phe Leu# 220- Thr Ser Val Thr Met Gln Ala Gly Pro Asn Ph - #e Arg Gln Arg Cys Gln225 2 - #30 2 - #35 2 -#40- Ser Tyr Thr Asp Ile Pro Trp Arg Glu Leu Ph - #e Ala Pro Lys Gly Ala# 255- Asp Gly Arg Thr Phe Glu Lys Phe Val Ala Gl - #u Ser Gly Gly Ala Glu# 270- Ala Ile Trp Tyr Pro Phe Thr Glu Lys Pro Tr - #p Met Lys Val Trp Thr# 285- Val Ser Pro Thr Lys Pro Asp Ser Ser Asn Gl - #u Val Gly Ser Leu Gly# 300- Ser Ala Gly Ser Leu Val Gly Lys Pro Pro Gl - #n Ala Arg Glu Val Ser305 3 - #10 3 - #15 3 -#20- Gly Pro Tyr Asn Tyr Ile Phe Ser Asp Asn Le - #u Pro Glu Pro Ile Thr# 335- Asp Met Ile Gly Ala Ile Asn Ala Gly Asn Pr - #o Gly Ile Ala Pro Leu# 350- Phe Gly Pro Ala Met Tyr Glu Ile Thr Lys Le - #u Gly Leu Ala Ala Thr# 365- Asn Ala Asn Asp Ile Trp Gly Trp Ser Lys As - #p Val Gln Phe Tyr Ile# 380- Lys Ala Thr Thr Leu Arg Leu Thr Glu Gly Gl - #y Gly Ala Val Val Thr385 3 - #90 3 - #95 4 -#00- Ser Arg Ala Asn Ile Ala Thr Val Ile Asn As - #p Phe Thr Glu Trp Phe# 415- His Glu Arg Ile Glu Phe Tyr Arg Ala Lys Gl - #y Glu Phe Pro Leu Asn# 430- Gly Pro Val Glu Ile Arg Cys Cys Gly Leu As - #p Gln Ala Ala Asp Val# 445- Lys Val Pro Ser Val Gly Pro Pro Thr Ile Se - #r Ala Thr Arg Pro Arg# 460- Pro Asp His Pro Asp Trp Asp Val Ala Ile Tr - #p Leu Asn Val Leu Gly465 4 - #70 4 - #75 4 -#80- Val Pro Gly Thr Pro Gly Met Phe Glu Phe Ty - #r Arg Glu Met Glu Gln# 495- Trp Met Arg Ser His Tyr Asn Asn Asp Asp Al - #a Thr Phe Arg Pro Glu# 510- Trp Ser Lys Gly Trp Ala Phe Gly Pro Asp Pr - #o Tyr Thr Asp Asn Asp# 525- Ile Val Thr Asn Lys Met Arg Ala Thr Tyr Il - #e Glu Gly Val Pro Thr# 540- Thr Glu Asn Trp Asp Thr Ala Arg Ala Arg Ty - #r Asn Gln Ile Asp Pro545 5 - #50 5 - #55 5 -#60- His Arg Val Phe Thr Asn Gly Phe Met Asp Ly - #s Leu Leu Pro# 570- (2) INFORMATION FOR SEQ ID NO: 28:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 1731 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear- (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 25..1731#28: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- GAATTCACAC AGGAAACAGA ATTC ATG GTT ATG CAC CAT G - #GG CAT GCC TCG 51#Gly His Ala Serl Met His His# 5 1- ACC GGG CCG GTC GCG CCG CTT CCG ACG CCG CC - #G AAC TTC CCG AAC GAC 99Thr Gly Pro Val Ala Pro Leu Pro Thr Pro Pr - #o Asn Phe Pro Asn Asp# 25- ATC GCG CTG TTC CAG CAG GCG TAC CAG AAC TG - #G TCC AAG GAG ATC ATG 147Ile Ala Leu Phe Gln Gln Ala Tyr Gln Asn Tr - #p Ser Lys Glu Ile Met# 40- CTG GAC GCC ACT TGG GTC TGC TCG CCC AAG AC - #G CCG CAG GAT GTC GTT 195Leu Asp Ala Thr Trp Val Cys Ser Pro Lys Th - #r Pro Gln Asp Val Val# 55- CGC CTT GCC AAC TGG GCG CAC GAG CAC GAC TA - #C AAG ATC CGC CCG CGC 243Arg Leu Ala Asn Trp Ala His Glu His Asp Ty - #r Lys Ile Arg Pro Arg# 70- GGC GCG ATG CAC GGC TGG ACC CCG CTC ACC GT - #G GAG AAG GGG GCC AAC 291Gly Ala Met His Gly Trp Thr Pro Leu Thr Va - #l Glu Lys Gly Ala Asn# 85- GTC GAG AAG GTG ATC CTC GCC GAC ACG ATG AC - #G CAT CTG AAC GGC ATC 339Val Glu Lys Val Ile Leu Ala Asp Thr Met Th - #r His Leu Asn Gly Ile#105- ACG GTG AAC ACG GGC GGC CCC GTG GCT ACC GT - #C ACC GCC GGT GCC GGC 387Thr Val Asn Thr Gly Gly Pro Val Ala Thr Va - #l Thr Ala Gly Ala Gly# 120- GCC AGC ATC GAG GCG ATC GTC ACC GAA CTG CA - #G AAG CAC GAC CTC GGC 435Ala Ser Ile Glu Ala Ile Val Thr Glu Leu Gl - #n Lys His Asp Leu Gly# 135- TGG GCC AAC CTG CCC GCT CCG GGT GTG CTG TC - #G ATC GGT GGC GCC CTT 483Trp Ala Asn Leu Pro Ala Pro Gly Val Leu Se - #r Ile Gly Gly Ala Leu# 150- GCG GTC AAC GCG CAC GGT GCG GCG CTG CCG GC - #C GTC GGC CAG ACC ACG 531Ala Val Asn Ala His Gly Ala Ala Leu Pro Al - #a Val Gly Gln Thr Thr# 165- CTG CCC GGT CAC ACC TAC GGT TCG CTG AGC AA - #C CTG GTC ACC GAG CTG 579Leu Pro Gly His Thr Tyr Gly Ser Leu Ser As - #n Leu Val Thr Glu Leu170 1 - #75 1 - #80 1 -#85- ACC GCG GTC GTC TGG AAC GGC ACC ACC TAC GC - #A CTC GAG ACG TAC CAG 627Thr Ala Val Val Trp Asn Gly Thr Thr Tyr Al - #a Leu Glu Thr Tyr Gln# 200- CGC AAC GAT CCT CGG ATC ACC CCA CTG CTC AC - #C AAC CTC GGG CGC TGC 675Arg Asn Asp Pro Arg Ile Thr Pro Leu Leu Th - #r Asn Leu Gly Arg Cys# 215- TTC CTG ACC TCG GTG ACG ATG CAG GCC GGC CC - #C AAC TTC CGT CAG CGG 723Phe Leu Thr Ser Val Thr Met Gln Ala Gly Pr - #o Asn Phe Arg Gln Arg# 230- TGC CAG AGC TAC ACC GAC ATC CCG TGG CGG GA - #A CTG TTC GCG CCG AAG 771Cys Gln Ser Tyr Thr Asp Ile Pro Trp Arg Gl - #u Leu Phe Ala Pro Lys# 245- GGC GCC GAC GGC CGC ACG TTC GAG AAG TTC GT - #C GCG GAA TCG GGC GGC 819Gly Ala Asp Gly Arg Thr Phe Glu Lys Phe Va - #l Ala Glu Ser Gly Gly250 2 - #55 2 - #60 2 -#65- GCC GAG GCG ATC TGG TAC CCG TTC ACC GAG AA - #G CCG TGG ATG AAG GTG 867Ala Glu Ala Ile Trp Tyr Pro Phe Thr Glu Ly - #s Pro Trp Met Lys Val# 280- TGG ACG GTC TCG CCG ACC AAG CCG GAC TCG TC - #G AAC GAG GTC GGA AGC 915Trp Thr Val Ser Pro Thr Lys Pro Asp Ser Se - #r Asn Glu Val Gly Ser# 295- CTC GGC TCG GCG GGC TCC CTC GTC GGC AAG CC - #T CCG CAG GCG CGT GAG 963Leu Gly Ser Ala Gly Ser Leu Val Gly Lys Pr - #o Pro Gln Ala Arg Glu# 310- GTC TCC GGC CCG TAC AAC TAC ATC TTC TCC GA - #C AAC CTG CCG GAG CCC1011Val Ser Gly Pro Tyr Asn Tyr Ile Phe Ser As - #p Asn Leu Pro Glu Pro# 325- ATC ACC GAC ATG ATC GGC GCC ATC AAC GCC GG - #A AAC CCC GGA ATC GCA1059Ile Thr Asp Met Ile Gly Ala Ile Asn Ala Gl - #y Asn Pro Gly Ile Ala330 3 - #35 3 - #40 3 -#45- CCG CTG TTC GGC CCG GCG ATG TAC GAG ATC AC - #C AAG CTC GGG CTG GCC1107Pro Leu Phe Gly Pro Ala Met Tyr Glu Ile Th - #r Lys Leu Gly Leu Ala# 360- GCG ACG AAT GCC AAC GAC ATC TGG GGC TGG TC - #G AAG GAC GTC CAG TTC1155Ala Thr Asn Ala Asn Asp Ile Trp Gly Trp Se - #r Lys Asp Val Gln Phe# 375- TAC ATC AAG GCC ACG ACG TTG CGA CTC ACC GA - #G GGC GGC GGC GCC GTC1203Tyr Ile Lys Ala Thr Thr Leu Arg Leu Thr Gl - #u Gly Gly Gly Ala Val# 390- GTC ACG AGC CGC GCC AAC ATC GCG ACC GTG AT - #C AAC GAC TTC ACC GAG1251Val Thr Ser Arg Ala Asn Ile Ala Thr Val Il - #e Asn Asp Phe Thr Glu# 405- TGG TTC CAC GAG CGC ATC GAG TTC TAC CGC GC - #G AAG GGC GAG TTC CCG1299Trp Phe His Glu Arg Ile Glu Phe Tyr Arg Al - #a Lys Gly Glu Phe Pro410 4 - #15 4 - #20 4 -#25- CTC AAC GGT CCG GTC GAG ATC CGC TGC TGC GG - #G CTC GAT CAG GCA GCC1347Leu Asn Gly Pro Val Glu Ile Arg Cys Cys Gl - #y Leu Asp Gln Ala Ala# 440- GAC GTC AAG GTG CCG TCG GTG GGC CCG CCG AC - #C ATC TCG GCG ACC CGT1395Asp Val Lys Val Pro Ser Val Gly Pro Pro Th - #r Ile Ser Ala Thr Arg# 455- CCG CGT CCG GAT CAT CCG GAC TGG GAC GTC GC - #G ATC TGG CTG AAC GTT1443Pro Arg Pro Asp His Pro Asp Trp Asp Val Al - #a Ile Trp Leu Asn Val# 470- CTC GGT GTT CCG GGC ACC CCC GGC ATG TTC GA - #G TTC TAC CGC GAG ATG1491Leu Gly Val Pro Gly Thr Pro Gly Met Phe Gl - #u Phe Tyr Arg Glu Met# 485- GAG CAG TGG ATG CGG AGC CAC TAC AAC AAC GA - #C GAC GCC ACC TTC CGG1539Glu Gln Trp Met Arg Ser His Tyr Asn Asn As - #p Asp Ala Thr Phe Arg490 4 - #95 5 - #00 5 -#05- CCC GAG TGG TCG AAG GGG TGG GCG TTC GGT CC - #C GAC CCG TAC ACC GAC1587Pro Glu Trp Ser Lys Gly Trp Ala Phe Gly Pr - #o Asp Pro Tyr Thr Asp# 520- AAC GAC ATC GTC ACG AAC AAG ATG CGC GCC AC - #C TAC ATC GAA GGT GTC1635Asn Asp Ile Val Thr Asn Lys Met Arg Ala Th - #r Tyr Ile Glu Gly Val# 535- CCG ACG ACC GAG AAC TGG GAC ACC GCG CGC GC - #T CGG TAC AAC CAG ATC1683Pro Thr Thr Glu Asn Trp Asp Thr Ala Arg Al - #a Arg Tyr Asn Gln Ile# 550- GAC CCG CAT CGC GTG TTC ACC AAC GGA TTC AT - #G GAC AAG CTG CTT CCG1731Asp Pro His Arg Val Phe Thr Asn Gly Phe Me - #t Asp Lys Leu Leu Pro# 565- (2) INFORMATION FOR SEQ ID NO: 29:- (i) SEQUENCE CHARACTERISTICS:#acids (A) LENGTH: 569 amino (B) TYPE: amino acid (D) TOPOLOGY: linear- (ii) MOLECULE TYPE: Protein#29: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:- Met Val Met His His Gly His Ala Ser Thr Gl - #y Pro Val Ala Pro Leu# 15- Pro Thr Pro Pro Asn Phe Pro Asn Asp Ile Al - #a Leu Phe Gln Gln Ala# 30- Tyr Gln Asn Trp Ser Lys Glu Ile Met Leu As - #p Ala Thr Trp Val Cys# 45- Ser Pro Lys Thr Pro Gln Asp Val Val Arg Le - #u Ala Asn Trp Ala His# 60- Glu His Asp Tyr Lys Ile Arg Pro Arg Gly Al - #a Met His Gly Trp Thr# 80- Pro Leu Thr Val Glu Lys Gly Ala Asn Val Gl - #u Lys Val Ile Leu Ala# 95- Asp Thr Met Thr His Leu Asn Gly Ile Thr Va - #l Asn Thr Gly Gly Pro# 110- Val Ala Thr Val Thr Ala Gly Ala Gly Ala Se - #r Ile Glu Ala Ile Val# 125- Thr Glu Leu Gln Lys His Asp Leu Gly Trp Al - #a Asn Leu Pro Ala Pro# 140- Gly Val Leu Ser Ile Gly Gly Ala Leu Ala Va - #l Asn Ala His Gly Ala145 1 - #50 1 - #55 1 -#60- Ala Leu Pro Ala Val Gly Gln Thr Thr Leu Pr - #o Gly His Thr Tyr Gly# 175- Ser Leu Ser Asn Leu Val Thr Glu Leu Thr Al - #a Val Val Trp Asn Gly# 190- Thr Thr Tyr Ala Leu Glu Thr Tyr Gln Arg As - #n Asp Pro Arg Ile Thr# 205- Pro Leu Leu Thr Asn Leu Gly Arg Cys Phe Le - #u Thr Ser Val Thr Met# 220- Gln Ala Gly Pro Asn Phe Arg Gln Arg Cys Gl - #n Ser Tyr Thr Asp Ile225 2 - #30 2 - #35 2 -#40- Pro Trp Arg Glu Leu Phe Ala Pro Lys Gly Al - #a Asp Gly Arg Thr Phe# 255- Glu Lys Phe Val Ala Glu Ser Gly Gly Ala Gl - #u Ala Ile Trp Tyr Pro# 270- Phe Thr Glu Lys Pro Trp Met Lys Val Trp Th - #r Val Ser Pro Thr Lys# 285- Pro Asp Ser Ser Asn Glu Val Gly Ser Leu Gl - #y Ser Ala Gly Ser Leu# 300- Val Gly Lys Pro Pro Gln Ala Arg Glu Val Se - #r Gly Pro Tyr Asn Tyr305 3 - #10 3 - #15 3 -#20- Ile Phe Ser Asp Asn Leu Pro Glu Pro Ile Th - #r Asp Met Ile Gly Ala# 335- Ile Asn Ala Gly Asn Pro Gly Ile Ala Pro Le - #u Phe Gly Pro Ala Met# 350- Tyr Glu Ile Thr Lys Leu Gly Leu Ala Ala Th - #r Asn Ala Asn Asp Ile# 365- Trp Gly Trp Ser Lys Asp Val Gln Phe Tyr Il - #e Lys Ala Thr Thr Leu# 380- Arg Leu Thr Glu Gly Gly Gly Ala Val Val Th - #r Ser Arg Ala Asn Ile385 3 - #90 3 - #95 4 -#00- Ala Thr Val Ile Asn Asp Phe Thr Glu Trp Ph - #e His Glu Arg Ile Glu# 415- Phe Tyr Arg Ala Lys Gly Glu Phe Pro Leu As - #n Gly Pro Val Glu Ile# 430- Arg Cys Cys Gly Leu Asp Gln Ala Ala Asp Va - #l Lys Val Pro Ser Val# 445- Gly Pro Pro Thr Ile Ser Ala Thr Arg Pro Ar - #g Pro Asp His Pro Asp# 460- Trp Asp Val Ala Ile Trp Leu Asn Val Leu Gl - #y Val Pro Gly Thr Pro465 4 - #70 4 - #75 4 -#80- Gly Met Phe Glu Phe Tyr Arg Glu Met Glu Gl - #n Trp Met Arg Ser His# 495- Tyr Asn Asn Asp Asp Ala Thr Phe Arg Pro Gl - #u Trp Ser Lys Gly Trp# 510- Ala Phe Gly Pro Asp Pro Tyr Thr Asp Asn As - #p Ile Val Thr Asn Lys# 525- Met Arg Ala Thr Tyr Ile Glu Gly Val Pro Th - #r Thr Glu Asn Trp Asp# 540- Thr Ala Arg Ala Arg Tyr Asn Gln Ile Asp Pr - #o His Arg Val Phe Thr545 5 - #50 5 - #55 5 -#60- Asn Gly Phe Met Asp Lys Leu Leu Pro 565- (2) INFORMATION FOR SEQ ID NO: 30:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 36 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear#30: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:# 36 GCCC GGTGGCGCCG CTTCCG- (2) INFORMATION FOR SEQ ID NO: 31:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 25 base (B) TYPE: Nukleins (C) STRANDEDNESS: single (D) TOPOLOGY: linear#31: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:# 25 GGTG ACGAT- (2) INFORMATION FOR SEQ ID NO: 32:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 39 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear#32: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:# 39 AAAC ATCGATGACC ATGATTACG- (2) INFORMATION FOR SEQ ID NO: 33:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 25 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear#33: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:# 25 GGTG ACGAT- (2) INFORMATION FOR SEQ ID NO: 34:- (i) SEQUENCE CHARACTERISTICS:#pairs (A) LENGTH: 18 base (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear#34: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:# 18 TG__________________________________________________________________________

Claims

1. A purified peptide cholesterol oxidase, comprising the amino acid sequence shown in SEQ ID NO:2, wherein said peptide does not include a B. sterolicum signal sequence.

2. Recombinant cholesterol oxidase comprising an N-terminal sequence selected from the group consisting of the sequences shown in SEQ ID NO 7, 9, 11, 13, 15 and 17.

3. Recombinant cholesterol oxidase of claim 2 comprising a sequence selected from the group consisting of the sequences shown in SEQ ID NO 19, 21, 23, 25, 27 or 29.

4. A DNA molecule, which codes for a peptide with cholesterol oxidase activity or a sequence which is complementary thereto and which is selected from the group consisting of:

a) the DNA sequence shown in SEQ ID NO 1 or a DNA sequence which is complementary thereto,

b) DNA sequences which hybridize with the DNA sequence shown in SEQ ID NO 1, and

c) DNA sequences which code for a peptide with the same amino acid sequence as the amino acid sequences coded by the DNA sequences of a) and b),

wherein said peptide is obtainable from B. sterolicum and can be expressed in an enzymatically active form in E. coli and wherein said DNA does not encode a B. sterolicum signal sequence.

5. The DNA of claim 4, comprising a 5' sequence selected from the group consisting of the sequences shown in SEQ ID NO 6, 8, 10, 12, 14 and 16.

6. The DNA of claim 4, comprising a sequence selected from the group consisting of the sequences shown in SEQ ID NO 18, 20, 22, 24, 26 and 28.

7. The DNA of claim 4, comprising the sequence shown in SEQ ID NO 1.

8. A process for the production of a recombinant cholesterol oxidase comprising:

a) transforming a host cell with an expression vector comprising the DNA of claim 4,

b) culturing the transformed host cells, and

c) isolating the cholesterol oxidase formed from the cytoplasm of the transformed cells.

9. The process of claim 8, wherein the DNA comprises a 5' sequence selected from the group consisting of the sequences shown in SEQ ID NO 6, 8, 10, 12, 14 and 16.

10. The process of claim 8, wherein the DNA comprises a sequence selected from the group consisting of the sequences shown in SEQ ID NO 18, 20, 22, 24, 26, and 28.

11. A method for the determination of cholesterol comprising combining the recombinant cholesterol oxidase according to claim 3 with a cholesterol containing sample under conditions suitable for the oxidation of cholesterol to cholesten-3-one and H.sub.2 .sub.2. and determining cholesterol-based on the presence of cholesten-3-one and .sub.2 O.sub.2.

12. A purified peptide cholesterol oxidase, consisting of the amino acid sequence shown in SEQ ID NO:2.